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This dissertation contains three different projects in proteomics and causal
inferences. In the first project, I apply a Bayesian hierarchical model to assess the
stability of phosphorylated proteins under short-time cold ischemia. This study pro-
vides inference on the stability of these phosphorylated proteins, which is valuable
when using these proteins as biomarkers for a disease. in the second project, I per-
form a comparative study of different confounding-adjusted to estimate the treatment
effect when the outcome variable is ordinal using observational data. The adjusted U-
statistics method is compared with other methods such as ordinal logistic regression,
propensity score based stratification and matching. In the third project, I perform
a causal analysis of the combination of dietary information and physical activity in
type 2 diabetes across different ethnic groups: White, African American and Mexican
American. Such information may contribute to a better understanding of type 2 dia-
betes variation between ethnic groups, and a better understanding of type 2 diabetes
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1.1 Bayesian Approach on Protein Phosphorylation Study
Phosphorylated proteins provide insight into tumor etiology and are used as diagnos-
tic, prognostic and therapeutic markers of complex diseases. However, pre-analytic
variations, such as freezing delay after biopsy acquisition, often occur in real hospital
settings and potentially lead to inaccurate results. The objective of the first project is
to develop statistical methodology to assess the stability of phosphorylated proteins
under short-time cold ischemia. We consider a hierarchical model to determine if
phosphorylation abundance of a protein at a particular phosphorylation site remains
constant or not during cold ischemia. When phosphorylation levels vary across time,
we estimate the direction of the changes in each protein based on the maximum over-
all posterior probability and on the pairwise posterior probabilities, respectively. We
analyze a dataset of ovarian tumor tissues that suffered cold-ischemia shock before the
proteomic profiling. Gajadhar et al. (2015) applied independent clusterings for each
patient because of the high heterogeneity across patients, while our proposed model
shares information allowing conclusions for the entire sample population. Using the
proposed model, 15 out of 32 proteins show significant changes during one-hour cold
ischemia. Through simulation studies we conclude that our proposed methodology
has a higher accuracy for detecting changes compared to an order restricted inference
method. Our approach provides inference on the stability of these phosphorylated
proteins, which is valuable when using these proteins as biomarkers for a disease.
1
This work is published The details of the work are presented in Chapter 2.
1.2 Comparative Study for Ordinal Outcomes using Observational
Data
Ordinal outcomes are frequently observed in the clinical studies, and also in the social
and economic sciences. The commonly used methods for analyzing ordinal outcome
include the parametric statistical methods (e.g., ordinal logistic regression model) and
the non-parametric statistics (e.g., the Mann-Whitney U test statistic). However, the
ordinal logistic regression model may be less robust when the model is misspecified,
and the classic Mann-Whitney U test does not have control of the confounding covari-
ates which may result in seriously biased estimates in the observational studies. The
propensity score based methods, such as matching, stratification, and inverse proba-
bility weighting method, have been applied to assess treatment effect with control of
confounding covariates. However, these methods usually assign the ordinal outcome
variables to numerical scores in the analysis, thus losing information about the nature
of ordinal variables. Glen, Kong and Datta (2017) propose an adjusted U-statistic to
estimate the treatment with control of the confounding covariates by using the inverse
probability weighting, which weights each subject into its study population, and the
weight for a subject is obtained from the propensity score. In this second project,
we provide a comparative study of different methods for estimating treatment effects
for ordinal outcome variables using observational data. We compare the adjusted U-
statistics method (i.e. the weighted Mann-Whitney U statistics) with other popular
used methods such as ordinal logistic regression, propensity score based stratification
and matching. Extensive simulation studies are carried out to compare the perfor-
mance of these methods under different situations, and pros and cons are presented.
A case study is constructed to assess the effect of physical activity on diabetic status
2
with controlling the confounding of the sociodemographic characteristics and dietary
information. This project is presented in Chapter 3.
1.3 Causal Analysis of T2DM using Path Analysis
Type 2 diabetes mellitus (T2DM) has become a major public health problem world-
wide and one of the major causes of mortality in the United States outstripping
cancer, HIV/AIDS, and cardiovascular disease. Enormous economic and psychoso-
cial consequences are also associated with T2DM (Menke et al., 2015; Zimmet et
al., 2016; Wang et al., 2016). It is important to examine the relationship between
diet and type 2 diabetes because food intake is considered as the crucial variable in
the control of T2DM. The second important component of T2DM control is phys-
ical activity. The National Health and Nutrition Examination Survey (NHANES)
continuous database includes physical activity and detailed information on dietary
components. These data have not been previously analyzed and may offer important
insights into dietary variability, physical activity and the management of T2DM. The
objective of the third project in this dissertation is to analyze the causal paths that
predict type 2 diabetes using data on demographics, dietary, BMI and physical activ-
ity. The analytical model is path analysis (i.e., causal structural equations) to explore
the relationships between variables that are clearly causal and outcomes (i.e., type 2
diabetes status). Via the causal analysis, the causal importance of these variables on




PROFILING THE EFFECTS OF SHORT TIME-COURSE COLD
ISCHEMIA ON TUMOR PROTEIN PHOSPHORYLATION USING
A BAYESIAN APPROACH1
2.1 Introduction
Protein tyrosine phosphorylation is considered to be a fundamental mechanism for
regulating many cellular functions. In this specific phosphorylation, a phosphate
group is added to the amino acid tyrosine on a protein. Disorders of tyrosine phos-
phorylation are believed to lead to many serious human diseases (Hunter, 2009). For
example, protein tyrosine phosphorylation is tightly regulated in normal cells, but
tyrosine kinases, whose activity controls tyrosine phosphorylation, are found to be
mutated or over-expressed in many human malignancies (Paul and Mukhopadhyay,
2004). Accurate and robust assessment of tyrosine phosphorylation in tumor biopsy
samples is thus necessary for understanding intracellular signaling networks and for
developing targeted therapies for cancer patients (Bonnas et al., 2012; Gajadhar et
al., 2015).
However, there may exist pre-analytic variations due to inconsistencies during
sample collection and processing in a clinical laboratory. One of these sources of
variations is cold ischemia. Also known as freezing delay time, cold ischemia is the
1Reproduce with permission from “Profiling the effects of short time-course cold ischemia on
tumor protein phosphorylation using a Bayesian approach” by You Wu, Jeremy Gaskins, Maiying
Kong and Susmita Datta, 2017. Biometrics. doi:10.1111/biom.12742. Copyright c© 2017, The
International Biometric Society.
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time between tissue specimen excision and the freezing of the sample. Although it
has been shown that global protein levels do not change up to one hour cold ischemia,
significant changes are observed in phosphorylated proteins at the phosphorylation
sites. Some of the phosphorylation sites even have rapid changes during the first 5
minutes of cold ischemia (Mertins et al., 2014; Gajadhar et al., 2015). The dynamic
nature of protein phosphorylation in tissue specimens may be due to the fact that the
kinases and phosphatases controlling the signaling pathways of phosphorylation are
still active ex vivo after tissue excision (Espina et al., 2008). Therefore, the fidelity
of a protein phosphorylation abundance, which is the relative intensity value used to
measure protein phosphorylation magnitude, cannot be guaranteed in excised tumor
tissues that undergo cold ischemia. Subsequently, the targeted therapeutic strategies
and clinical decisions based on phosphorylation studies may not be accurate. To
ensure trustworthy results, it is necessary to examine whether the phosphorylation
level of a specific protein at a specific site is affected by short time cold ischemia.
This may determine the suitability of that phosphorylated protein to be considered
as a stable biomarker for a disease.
Although some phosphorylated proteins have been observed to be affected by
short time cold ischemia in the literature, few of those studies comprehensively exam-
ine the stability of phosphorylation over an entire sample population (Gajadhar et al.,
2015; Espina et al., 2008; Gu¨ndisch et al., 2013). As mentioned by Montana, Berk
and Ebbels (2011), most metabolomic experiments only produce short time-course
data with less than 10 time points, and the classical time series analysis cannot be
applied. Gajadhar et al. (2015) examined the cold ischemia induced changes in
phosphorylation by applying an affinity propagation clustering analysis to an ovarian
tumor dataset from 5 patients. However, due to the high level of heterogeneity across
patients, an independent clustering was formed for each patient, and it is challenging
to draw conclusions for the entire population. In this article, we construct a novel
5
hierarchical Bayesian model to examine whether the phosphorylation of each protein
at a particular site stays stable or not under cold ischemia shock. When the phos-
phorylation levels at a particular site vary across time points, we further estimate
the direction of the changes based on whether their abundances are increasing or
decreasing between two adjacent time points. By utilizing random effects to capture
the dependence between the observed phosphorylation abundances across different
time points and different phosphorylated proteins, we develop a model that shares
information across patients and allows us to draw conclusions for the entire sample
population.
Our proposed Bayesian model is presented in Section 2.2. We also briefly describe
an existing method proposed by Peddada et al. (2003) which can potentially be used
to analyze this short time course data. The work of Peddada et al. (2003) is based
on order restricted inference (ORI) for the analysis of a short time-course microarray
data. In Section 2.3, we apply our proposed method and the competitor ORI ap-
proach to examine the stability of each phosphorylated protein under one hour cold
ischemia shock using an ovarian tumor dataset from Gajadhar et al. (2015). We
further verify our method using a simulation study in Section 2.4 and provide some
concluding remarks in Section 2.5.
2.2 Methods
2.2.1 Hierarchical Bayesian model
Suppose that there are N patients in the study. We consider J common phosphory-
lated proteins, and each protein has only one phosphotyrosine (pTyr) site. For each
patient the abundance of phosphorylation at the jth pTyr site (j = 1, . . . , J) is mea-
sured at T common time points. At the tth time point (t = 1, . . . , T ), At represents
the number of minutes of freezing delay after sample excision (i.e., minutes of cold
6
ischemia). The abundance of phosphorylation at the jth pTyr site at the tth time
point for the ith patient is denoted as Yijt (i = 1, . . . , N ; j = 1, . . . , J ; t = 1, . . . , T ).
The unknown true population mean of the response profile at the jth pTyr site is
expressed as µj = (µj1, µj2, . . . , µjT )
′
.
Our primary goal is to examine the stability of each phosphorylated protein
and then further classify the detected unstable proteins according to their changes in
phosphorylation abundance between two adjacent time points. We characterize the
changes for each site into c = 2T−1 + 1 classes. The null profile is set as C0 = {µj ∈
RT : µj1 = µj2 = · · · = µjT}, indicating that there is no change in phosphorylation
abundance under cold ischemia shock over time. Each of the remaining classes has the
form Cr = {µj ∈ RT : µj1µj2 · · ·µjT} (r = 1, . . . , 2T−1), where  is either < or
>. Our primary objective is to learn if j ∈ C0 versus any of the other classifications.
The secondary objective is to learn which Cr is the most probable class for sites not
in the null profile.
To model the changes of phosphorylation during one hour of cold ischemia, we
consider a hierarchical random effect model of the following form:
Yijt = µjt + γi + ηij + δit + εijt. (2.1)
The main quantity of interest µjt represents the mean abundance of phosphoryla-
tion at the jth pTyr site and the tth time point. Because the measurements for
each patient across multiple sites and multiple time points are dependent, appro-
priate techniques are required to make an efficient and valid inference. The overall
variation across patients is explained by γi (i = 1, . . . , N). Variation across differ-
ent pTyr sites within the ith patient is explained by the site-specific random effect
ηi = (ηi1, ηi2, . . . , ηiJ)
′
. The patient-specific temporal effect is captured by the ran-
dom effect δi = (δi1, δi2, . . . , δiT )
′
, representing the time effect for the ith subject. The
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random error εijt is assumed to be normally distributed with mean 0 and variance
σ2.
In this work, a Bayesian approach is considered for the inference. Due to
normality of the random errors, the data is distributed as Yijt ∼ N(µjt + γi + ηij +
δit, σ
2). The overall effect from the ith patient, γi, is modeled by a normal distribution
with mean 0 and variance σ2γ. The site-specific random effect within the i
th patient
is modeled by ηij ∼ N(0, σ2η) (j = 1, . . . , J). The distribution of the temporal effects
is δi ∼ MVN(0, σ2δR(ρ)). We assume an auto-regressive correlation structure for
R(ρ) with corr(δit, δit′) = ρ
|At−At′ |/s, although other choices are possible. Here, ρ
represents the correlation between responses s minutes apart, and we use the value
of s = 10 minutes throughout. Recall that At represents the number of minutes of
cold ischemia.
Our primary goal is to determine if there are overall changes in the abundance
at the jth site, that is, if j ∈ C0 or if j is in one of the other profiles. To that end,
we introduce the random variable Zj ∼ Bernoulli(θ) to indicate whether there is
variation in phosphorylation abundance at the jth pTyr site during cold ischemia. The
parameter θ represents the overall proportion of sites with ischemia-induced changes.
The prior distribution of the trajectory µjt is set as µjt|(µ∗j , Zj) ∼ N(µ∗j , Zjσ2µ), where
µ∗j ∼ N(µ0, σ2µ∗) gives the average value across all the T time points. If Zj = 0, the
µjts are equal to µ
∗
j across all the time points, i.e., the j
th pTyr site is classified to
the null profile C0. If Zj = 1, µjt varies across time, and the j
th site is impacted
by cold ischemia. A site with Zj = 1 is classified to one of the candidate profiles
C1, . . . , Cc−1 based on the inequality directions in µj across all the time points. The
prior distribution of the overall mean µ0 is set as normal distribution with mean 0
and standard deviation 100.
Conjugate prior distributions for the error variance σ2 and fixed effect variance
components σ2µ and σ
2
µ∗ are set as inverse-gamma distribution with both shape and
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scale parameters at 0.1. Since we expect that the overall patient effect γi, patient-
specific temporal effect δit and site-specific effect ηij have smaller impact on the
response compared to µj, the prior distributions for the standard deviations σγ, ση,
and σδ are set as half-Cauchy distributions with medians (equivalent to the scale
parameter) of 0.1. The half-Cauchy is a common prior for the standard deviation of
a regression coefficient or shrinkage effect as it has a non-zero density at 0 (unlike
inverse-gamma distribution) allowing a small value for the variance term. Further,
the heavy tail of the half-Cauchy prior protects from over-shrinkage by allowing large
values when the effect is highly influential (Gelman, 2006; Carvalho, Polson and Scott,
2010). The correlation parameter ρ is given a uniform distribution from 0 to 1 as a
prior distribution. The prior for θ, the population proportion of sites impacted by
cold ischemia, is taken to be Beta(1, 1) (i.e., Uniform[0, 1]).
2.2.2 Estimation and inference of profile classification
Markov chain Monte Carlo (MCMC) sampling is applied to obtain a posterior sample
of size M . For each phosphorylation site j, denote the mth sample of the posterior
trajectory µj as µ
(m)
j (m = 1, . . . ,M). First, we consider testing H0j : Zj = 0 vs.
H1j : Zj = 1 to examine whether the j
th site is impacted by cold ischemia. P (Zj =
1|Y ) is estimated by the proportion of MCMC iterations with Z(m)j = 1. The jth site
is classified to the alternative profiles if Pˆ (Zj = 1|Y ) is greater than 0.5, which is the
Bayes decision rule corresponding to the 0− 1 loss function L(Zj, Zˆj) = I(Zj 6= Zˆj).
If we choose to penalize Type I and Type II errors differently, the 0.5 threshold can
be adjusted. Placing a non-degenerate prior on θ, the overall probability of changes,
guarantees an automatic multiplicity correction over our tests based on Zj (Scott and
Berger, 2010). This approach allows us to maintain the false discovery rate when we
consider whether µj varies across T time points (i.e., Zj = 1) over a potentially large
number of sites J .
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If H0j : Zj = 0 is rejected, our secondary objective is to estimate the changes
in direction of the unstable phosphorylated proteins. To estimate the profile of the
jth site, we consider two competing estimators: the maximum a posteriori (MAP)
estimator and maximum pairwise (MPW) estimator. Both estimators are formed
conditionally on the conclusions for H0j vs. H1j. If the posterior probability P (Zj =
0|Y ) is larger than the threshold value (typically, 0.5), then the jth site maintains a
membership in the null profile C0, indicating no change in phosphorylation abundance
during cold ischemia. Otherwise, we reject H0j, conclude that the j
th pTyr site varies
across T time points, and classify the jth site to its most likely profile. Using the MAP
estimator, we place the jth pTyr site that rejects H0j to the profile that maximizes the
estimated posterior probability Pˆ (µj ∈ Cr|Y ) (r = 1, . . . , c − 1), which is the profile






For the MPW estimator, the pTyr site that rejects H0j is classified to one of
the candidate profiles (C1, . . . , Cc−1) by estimating the direction of change between
adjacent measurements pairwise. Choosing the inequality between a pair of values
µj,t−1 and µjt is based on choosing the larger of Pˆ (µj,t−1 < µjt|Y ) and Pˆ (µj,t−1 >
µjt|Y ). The sequence of pairwise-estimated inequalities is used to determine the class
of the phosphorylated protein.
In general, one would expect that the MAP estimator produces more accurate
classification as it takes the full vector µj into consideration. However, the MAP
estimator is based on the number of iterations that µj visits each of the 2
T−1 non-
null profiles Cr during the MCMC run. When T is large relative to the length of
the MCMC chain, even the most probable profiles are visited infrequently, and the
estimated posterior probabilities Pˆ (µj ∈ Cr|Y ) may have large variabilities relative
to the differences between the more likely profiles. Conversely, the marginal pairwise
probabilities Pˆ (µj,t−1 < µjt|Y ) and Pˆ (µj,t−1 > µjt|Y ) typically have small variabili-
ties. Therefore, the MPW estimator may provide preferable classification for a large
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T . This issue is similar in spirit to choosing between the MAP and median model esti-
mators in Bayesian variable selection (see e.g., George and McCulloch, 1993; Barbieri
and Berger, 2004).
To describe the confidence in classification, we form a credible set Cj,1−α for
each site j where Pˆ (µj ∈ Cj,1−α|Y ) ≥ 1 − α. For the MAP estimator, the profiles
that are included in the 100(1− α)% credible set are determined by their estimated
posterior probabilities. For each phosphorylated protein, we sort Pˆ (µj ∈ C0|Y ),
Pˆ (µj ∈ C1|Y ), . . ., Pˆ (µj ∈ Cc−1|Y ) in decreasing order. Then the top candidate
profiles are included in the credible set until their cumulative posterior probability
is greater than 100(1 − α)% . For the MPW estimator, a similar procedure can be
performed using the product of the posterior probabilities between each of the two
adjacent time points to approximate the posterior probability of each profile.
2.2.3 ORI method
As a comparison to our proposed methodology, we also apply an order restricted
inference (ORI) algorithm developed by Peddada et al. (2003). This ORI method is
one of the most commonly used methods developed for analyzing short time-course
microarray data. It can also be applied to this phosphorylation abundance data. We
briefly describe the method here. The sample mean vector of the jth pTyr site is
denoted as Y¯j = (Y¯j1, . . . , Y¯jT )
′.
First, a collection of the candidate profiles C1, . . . , Cp is specified. The collec-
tion may or may not be the full set of 2T−1 possible non-zero profiles. Second, for
each candidate profile, point estimation follows the procedures proposed by Hwang
and Peddada (1994), which use an isotonic regression estimator for the general or-
dering cases. For each profile, the nodal parameter is the key for the estimation
procedure. The nodal parameters in each profile are defined as the parameters which
are linked to all the other parameters, where the two parameters are linked if the in-
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equalities between them are pre-specified. For example, in the case that T = 4, nodal
parameters are µ1, µ2, µ3 and µ4 in the candidate profile C = {µ1 < µ2 < µ3 < µ4};
in the candidate profile C = {µ1 < µ2 < µ3 > µ4}, µ3 is the only nodal parameter
(see Table A1.1 in the Appendix for the details when T = 4). For the nodal parame-
ters, an ordered sequence of parameters can be formed as µj(1) ≤ µj(2) ≤ . . . ≤ µj(T ),
where one may arbitrarily assign an inequality between the two parameters if their
relationship is unknown. Based on the ordered sequence, the estimate of the nodal
parameter µjt is found using the following formula:








where Y¯j(k) is the sample mean based on nj(k) observations. For a non-nodal pa-
rameter, say µjt′ , the largest sub-profile with µjt′ as a nodal parameter needs to be
identified, then µjt′ is estimated by using the formula above for the nodal parameters
and the data corresponding to the sub-profile. For the parameters in a profile without
any nodal parameters, the largest sub-profile with at least one nodal parameter needs
to be identified, and the parameters in the sub-profile can be estimated using the
methods for the profiles with nodal parameters. The procedure is repeated until all
of the parameters are estimated. Once a parameter is estimated, the estimate of this
parameter should be used in the estimation of the other unknown parameters.
Hypothesis testing for H0 : µj ∈ C0 vs. H1 : µj ∈ ∪pk=1Ck (equivalent to our
test of H0 : Zj = 0 vs. H1 : Zj = 1) is performed using a bootstrap approach. In each
bootstrap step, the maximum difference of two linked parameters is calculated for
each candidate profile. Then the largest maximum difference among the p candidate
profiles can be obtained for each bootstrap sample. The hypothesis test is performed
based on the bootstrap distribution of the largest maximum difference. If H0 is
rejected, the site is classified to the profile with the largest maximum difference. Full
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details can be found in Peddada et al. (2003).
2.3 Application to an ovarian tumor dataset
2.3.1 The ovarian tumor data
The ovarian tumor data from Gajadhar et al. (2015) is used to illustrate our proposed
methodology. Ovarian tumor tissues were collected from N = 5 patients. Tumor spec-
imens were collected across T = 4 time points at 0, 5, 30 and 60 minutes of freezing
delay after the surgical removal. After protein extraction, digestion and phospho-
tyrosine peptides enrichment, the peptides are separated using a mass-spectrometry
based analysis. The phosphotyrosine peptides and proteins are identified and quan-
tified subsequently.
Only the phosphorylated proteins with one phosphotyrosine position are con-
sidered in the study. The values of phosphorylation abundance are relative intensities
determined by iTRAQ quantification. For relative quantification of the four time
points, peptide samples were chemically labeled with different iTRAQ reagents and
then mixed into a single sample. These tags get covalently attached to the amine
groups of the N termini of peptides and lysine side chains. The mixed sample then
get fragmented in the mass spectrometer and reporter ions at defined masses (includ-
ing the masses of the pTyr sites) get released. Ratios of these reporter ions to one
another are treated as relative abundance, and the intensity of the masses at the initial
time point is treated at the reference abundance (Gajadhar et al., 2015). In order to
find the general characteristics of the phosphorylated sites, only the phosphorylated
proteins that are common to all patients are included in the following analysis. After
excluding the proteins with multiple phosphotyrosine positions, J = 32 common pTyr
sites are used in the analysis.
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2.3.2 Results
The sampling procedure for our Bayesian methods is implemented using WinBUGS
(Spiegelhalter et al., 1999) and R (R Core Team, 2014). Copies of the WinBUGS and
R codes can be found in the online supplementary materials. Running the MCMC
sampling procedure for 50,000 iterations with a burn-in of 5000 and thinning rate of 5
takes 3.02 minutes. The hypothesis H0j : Zj = 0 is rejected if Pˆ (Zj = 1|Y ) > 0.5, and
both MAP and MPW estimators are used to classify each phosphorylated protein.
The testing and classification results based on these two Bayesian estimators are
exactly the same.
Figure 2.1 shows the estimated trajectories with 95% credible intervals (CI)
(1st and 3rd columns) and MPW estimators (2nd and 4th columns) of six representa-
tive phosphorylated proteins. The gray lines represent the observed phosphorylation
abundance of each patient. The boxes in the MPW plots represent the posterior
probabilities of an equal, decreasing, or increasing trend of phosphorylation abun-
dance between each pair of adjacent time points, and the shaded box indicates the
MPW-chosen classification. For example, both phosphorylation sites of DYRK1A
and CDK1 are classified to the null profile C0 with Pˆ (Z = 0|Y ) = 0.98 and 0.95, re-
spectively. Sites of FYB, MAPK7, GAB1 and MAPK14 are classified to the non-null
profiles.
Figure 2.1 also shows that some phosphorylation sites have similar phosphory-
lation trajectories across all five patients (DYRK1A and MAPK7), while some other
sites (CDK1 and MAPK14) have greater heterogeneities across patients. For exam-
ple, the flat trajectory seen in phosphorylated protein CDK1 may be partly due to
the conflicting effects of the patient-dependent variations. The plots of estimated
profiles and MPW estimator for all phosphorylated proteins can be found in Figures
A1-A4 in the Appendix.
Detailed classification results from the Bayesian model are shown in Table
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2.1 with the probabilities of being classified to the null profile (4th column) and the
posterior probabilities of being classified to the corresponding profiles based the MAP
estimator (5th column). The profiles included in the 75% credible set are reported
in the last column in Table 2.1. Recall the site’s trajectory is estimated to be one
of the profiles in this set with at least 75% posterior probability. 17 pTyr sites were
classified to the null profile, indicating that the phosphorylation abundance does not
change during one-hour cold ischemia based on both estimators. The pTyr sites of
DOK1, INPP5D and MPZL1 show an increasing trend (C1), while the sites of CDKL5,
EPHA2, FYB and PRKCD show a decreasing trend during one hour cold ischemia
(C8). Some of our classification results are consistent with the clustering results in
Gajadhar et al. (2015). For example, ANXA2 and FLNA were classified to the null
profile C0 based on our proposed model, and they were also classified to the cluster
with minimal quantitative fluctuations in Gajadhar et al. (2015). MAPK14 showed
a rapid increase in phosphorylation within 5 minutes cold ischemia in Gajadhar et al.
(2015), and it was classified to the candidate profile C3 with similar characterization
based on our Bayesian model. However, the conclusions in Gajadhar et al. (2015) are
based on a single sample, while our conclusions are based on all samples and should
be more robust.
Table 2.2 shows the posterior median and 95% credible interval (CI) for each
model parameter. The estimated standard deviations for the patient and site-specific
components, σγ and ση , are quite small, indicating the impact of our half-Cauchy
shrinkage prior. Conversely, the standard deviation of the temporal effect σδ is much
larger (roughly 60% of the standard deviation for error), while the correlation is low
(ρ = 0.13). Thus, variation across T time points is the key driver of the covariance
structure, not the variation across patients or sites. By including the within patient
temporal effect and site-specific effect, we are able to cohesively distinguish between
the roles of protein trajectory µjt and the patient trajectory δit, while Gajadhar et al.
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(2015) performs patient-specific analysis which potentially confounds the two sources
of variation.
Classification was also done using the ORI method. Detailed results of ORI
profiling with p-values for the test of H0 : µj ∈ C0 versus H1 : µj ∈ ∪c−1k=1Ck can be
found in Table A1.2 in the Appendix. Table 2.3 compares the classifications from the
Bayesian approach to those from the ORI method. Of the 17 pTyr sites classified
to the null profile by the Bayesian method, the ORI method classifies 14 of these to
the null profile and 3 to the non-null profiles. There is one profile which the ORI
method classifies to the null profile, however, the Bayesian method classifies to the
non-null profile. In total, 23 pTyr sites (71%) were classified to the same profiles
using both methods. The total computation time using the ORI method was 26.4
minutes, almost seven times longer than our Bayesian method.
2.4 Simulation Study
To verify our approach and compare the results with the ORI method, we conduct
a simulation study with varying sample sizes and number of time points. In each
simulation, N subjects are generated, and each subject is observed at T time points
and J pTyr sites. We assign the true profile for each of the J pTyr sites as follows.
When T = 4, the 20% of sites are assigned to the null profile C0, then 5% to profile C1,
and similarly, 10%, 10%, 5%, 15%, 5%, 15% and 15% of sites are assigned to profiles
C2 to C8, respectively. The trajectories µjts are randomly sampled from the sequence
from -3 to 5 with increments 0.5 according to these pre-specified profiles. Data are





δ are all set as 0.1. The temporal correlation coefficient
ρ is set as 0.5. 200 simulated datasets are generated and analyzed using both ORI
algorithm and our Bayesian model.
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2.4.1 Assessing the effect of sample size
The first simulation study is run with N = 5, J = 35, T = 4, and the time points
are chosen as 0, 5, 30, and 60 minutes, which is similar to the setting of ovarian
tumor data. Another simulation study is carried out with an increased sample size
of N = 20. We draw 200 simulated datasets for each simulation setting. To evaluate
the performance of our procedure, we consider the following four quantities: Type I
error rate, Type II error rate, the overall correct classification proportion, and the
accuracy of trajectory estimation. To measure the accuracy of the estimation for µ,





based on the posterior mean of µˆjt. All accuracy measurements are averaged over 200
simulated datasets.
Table 2.4 shows the simulation results of the two scenarios introduced above
with N = 5 and N = 20. For the simulation with N = 5, the overall mean proportion
of correct classification using the ORI method is 68.3%, compared to 94.1% from our
Bayesian model using both the MAP and MPW estimators, corresponding to roughly
9 additional correctly assigned sites. The probabilities of making a Type I error
P (µj ∈ ∪c−1k=1Cˆk|µj ∈ C0) in our proposed model and ORI methods are 4% and 5%,
respectively. The Type II error rates P (µj ∈ Cˆ0|µj ∈ ∪c−1k=1Ck) are around 0.2% for
both the MAP and MPW estimators, compared to 0.4% based on the ORI method,
indicating that all methods have high power in this scenario. The measurement for the
accuracy of the estimated trajectory (lower SSE corresponds to a greater accuracy)
is 18.5 for the Bayesian model compared to 54.1 for the ORI method, indicating that
our model more accurately estimates the trajectory µj than the ORI method.
For the simulation with increased sample size with N = 20, the mean of
the correct classification proportions of pTyr sites using the ORI method is 71.2%
compared to 99.5% using both the estimators of our Bayesian model. Both of our
proposed model and the ORI method accurately assign sites to the null, while our
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Bayesian model does better in distinguishing the non-null profiles. In this scenario,
our Bayesian model also performs better for estimating the trajectory than the ORI
method.
We also construct the 75% credible sets in both the simulation settings. The
proportions that the true profile is included in the 75% credible set are 98.5% and
99.9% for N = 5 and 20, respectively. Thus, we have confidence that in the rare case
when the estimated profile is incorrect, the true classification is almost always in the
credible set.
2.4.2 Assessing the effect of the signal-to-noise ratio and number of time points
We conduct additional simulation studies to examine the performance of our model
under different signal-to-noise ratios and different numbers of time points. In the
following simulation scenarios, we let N = 20 and J = 35 and consider three settings
for T : T = 4, 5, and 8. For T = 4, each site is assigned to one of the 9 candidate
profiles as in the previous section. However, as T increases, the number of candidate
profiles increases exponentially. This is particularly challenging for the ORI method
because its algorithm involves a recursive estimation scheme for each profile under
consideration. To that end, we apply the ORI method to a restricted set of profiles,
which are known to contain the set of true profiles. For T = 5, 11 out of 17 candidate
profiles (including the null) are selected, representing 65% of the total number of
possible profiles. For T = 8, the restricted set contains 15 out of 129 profiles, roughly
12% of all possible profiles. Table A1.3 in the Appendix reports the selected profiles
and the percentage of the true assignment for the cases when T = 5 and 8.
In addition to examining the impact of T on accuracy, we also consider changes
to the signal-to-noise ratio (i.e., effect size). For the largest effect size, µjt are drawn
uniformly from the sequence from -3 to 5 with an increment of 0.1, subject to the
profile membership. The medium effect size draws µjt from the sequence from -1.5
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to 2.5 with an increment of 0.05, and the smallest effect size uses -0.75 to 1.25 with
an increment of 0.025. The ORI method is applied to find the best profile among
the selected set of the candidate profiles. To determine the accuracy without any
additional knowledge of the restricted profile set, the MAP and MPW classifications
are found as before. To compare against the ORI estimator that uses the selected
profile set, we develop corresponding versions of the MAP and MPW estimators that
use this extra knowledge. For the MAP estimator, we choose the candidate profile
which has the maximum among Pr(µj ∈ Cr|Y ) among r in the selected profile set.
For the MPW estimator, we choose the profile from among the selected set with the
maximum value of
∏T−1
t=1 Pr(µjttµj,t+1|Y ), where t is the tth inequality in Cr.
Figure 2.2 shows the boxplots of the correct classification rates under the
different simulation scenarios. In the T = 4 case, the mean correct classification rates
of both the MAP and MPW methods are higher than the ORI method under all
effect sizes. As the number of time points increases and/or the effect size decreases,
correct classification becomes more challenging, and the accuracy deteriorates for all
methods. However, across all scenarios the Bayesian methods that use the selected
set of profiles consistently beat (often by a large margin) the ORI in accuracy. In
fact, even without using the extra information on the restricted set of profiles, our
Bayesian classification is often more accurate than the ORI (e.g., for all the effect
sizes for T = 4 and 5, and for the large effect size for T = 8). Comparing the two
estimators, we find that the MAP and MPW estimators are roughly equivalent for the
small number of time points, and the MPW estimator is slightly better for the larger
number of time points, which is consistent with the intuition discussed in Section
2.2.2. See Table 2.5 for detailed results of each simulation scenario. Figure 2.3 shows
the boxplots of the accuracy of the estimated trajectories measured by SSE. In all
cases, the Bayesian model performs better than the ORI method in estimating the
trajectory µjt.
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2.5 Discussion and Conclusion
In this project we develop a Bayesian methodology to examine the stability of tyrosine
phosphorylated proteins undergoing cold ischemia and to characterize the direction
of changes in the unstable ones. From the ovarian tumor data, 15 out of 32 phospho-
rylated proteins show significant changes during one-hour cold ischemia based on our
Bayesian model, indicating that any scientific results related to these phosphorylated
proteins may be altered by a short freezing delay after the tumor specimen excision.
A number of phosphorylated proteins that we identified as fluctuating in phos-
phorylation abundance under cold ischemia shock have been found to be medically
important for therapy development or biomarker discovery in the literature. For ex-
ample, DOK1 has been identified as a candidate tumor suppressor gene for various
human malignancies (Lee et al., 2007; Berger et al., 2010) and works in a signal trans-
duction pathway downstream of receptor tyrosine kinases (Ne´morin et al., 2001). This
phosphorylated protein shows an increasing trend in phosphorylation abundances un-
dergoing one hour cold ischemia shock in our study. GAB1, which serves in a different
signaling pathway, was classified to the profile with an increase in phosphorylation
abundance during the first 30 minute cold ischemia and a decrease during the next 30
minute cold ischemia based on our Bayesian model; it was also classified to the cluster
characterized by a rapid increase in phosphorylation within 5 minutes of cold ischemia
in Gajadhar et al. (2015). It has been found that GAB1 is usually over-expressed
in cancer cells and may be used as a target for cancer therapy, especially for triple
negative breast cancer patients (Chen et al., 2015; Gu and Neel, 2003). Similarly,
EPHA2 has been found to be over-expressed in various cancers, particularly a high
level of EPHA2 is detected in malignant cancer-derived cell lines and advanced forms
of cancer (Tandon, Vemula and Mittal, 2011). EPHA2 displayed a decreasing trend
in phosphorylation abundance during one hour cold ischemia based on our approach
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and was also classified to the gradually decreased cluster in Gajadhar et al. (2015). It
should be noted that PEAK1 may require a more careful sample collection protocol
compared to the other phosphorylated proteins classified to the null profile. While
the most probable explanation is that PEAK1 is not impacted by freezing delay, the
non-null profile C6 = {µ ∈ R4 : µ1 > µ2 < µ3 > µ4} is contained in the credible set,
so the potential impact of cold ischemia should not be totally discounted.
Based on the simulation studies, our Bayesian model is more efficient for the
classification of short time-course data than the ORI algorithm. Both our Bayesian
model and the ORI method have high correct classification rates for the null profile
C0. However, our Bayesian model has a much higher accuracy in correctly classifying
the non-null profiles than the ORI method. The Bayesian approach performs well
even in the cases with more time points and small effect sizes. In addition to the
improved accuracy, the computation speed of our Bayesian approach is much faster
than the ORI method. In the simulation study with T = 8, it takes approximately 6
hours per dataset to use the ORI method on the subset of 15/129 profiles, whereas
the Bayesian approach which considers all profiles requires only a third of the time.
Since the primary focus is whether the protein phosphorylation status has
changed during one-hour cold ischemia, we only consider complete equality or a se-
quence of strict inequalities between each pair of time points. If the changes in
phosphorylation abundance under a certain threshold need to be considered as equal,
some extensions of our model can be considered. Wu et al. (2007) provides a similar
approach using a 3-stage Markov model using the relationships <, > and = between
two time points. However, they do not consider the role of the site or temporal de-
pendence. As a simple ad hoc version, one might extend our method to allow the
profiles with relationships <, > and = by choosing a cut-off value for approximate
equality either through biological considerations or a default value. The pair µjt and
µj,t+1 would be considered to be approximately equal if |µjt − µj,t+1| < , increasing
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if µjt +  < µj,t+1, and decreasing if µjt−  > µj,t+1, where  is a pre-specified positive
value. A MAP or MPW estimator from the set of 3T−1 profiles can be found.
A key concern for an analysis with few patients is the validity of the normality
assumption. A Q-Q plot and histogram of the standardized residuals (Yijt − µˆjt −
γˆi − δˆit − ηˆij) can be found in Figure 2.4. The Q-Q plot indicates that the normal-
ity assumption is reasonably satisfied in our analysis of the ovarian tumor data. If
normality was found to be suspect, a transformation of the data (e.g., logarithm or
Box-Cox) or a thicker-tailed or skewed distribution for ijt, such as the t-distribution
or skewed normal distribution, could easily be incorporated.
The phosphotyrosine signaling networks can be affected by cold ischemia shock
for many phosphorylated proteins, even in a short time period. Our study shows that
nearly half of the selected phosphorylated proteins experience a dramatic change
during one-hour cold ischemia, which underscores the necessity of freezing the tissue
sample immediately after excision. Because the phosphorylation changes of some
pTyr sites classified to C0 may be dramatically different among patients (see MAPK14
in Figure 2.1), these sites may require further attention. The current work provides
an efficient method to detect unstable phosphorylated proteins under short-time cold
ischemia shock and profile the direction of their changes. Thus, the results obtained
from our method may provide valuable guidance on developing sample collection
protocols and further analytical strategies.





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2.2: Posterior median and 95% CI for each model parameter
Posterior Median 95% CI
σ 0.173 (0.164, 0.185)
µ0 1.002 (0.929, 1.078)
σµ 0.278 (0.228, 0.347)
σµ∗ 0.104 (0.080, 0.141)
σγ 0.017 (0.002, 0.076)
ση 0.003 (0.000, 0.017)
σδ 0.107 (0.076, 0.161)
ρ 0.131 (0.005, 0.504)
θ 0.487 (0.309, 0.673)
Table 2.3: Comparison of classifications from the ORI and MAP estimators for the
human tumor data.
ORI Method
C0 C1 C2 C3 C4 C5 C6 C7 C8
Bayesian Approach
(MAP)
C0 14 0 1 0 0 0 2 0 0
C1 0 1 2 0 0 0 0 0 0
C2 0 0 2 0 0 0 0 0 0
C3 0 0 0 1 0 0 0 0 0
C4 0 0 0 0 0 0 0 0 1
C5 0 0 0 0 0 0 1 0 0
C6 1 0 0 0 0 0 0 0 0
C7 0 0 0 0 0 0 0 1 1
C8 0 0 0 0 0 0 0 0 4
Table 2.4: Simulation results from Section 2.4.1. 200 simulated datasets with J = 35
and T = 4 were used in both the simulation settings. In each simulation, 8 pTyr
sites were assigned to the null profile C0 and 27 pTyr sites were assigned to the
other candidate profiles. The quantities reported in this table are averaged across
200 simulated datasets. The accuracy of the estimated trajectory is measured by the
sum of squared errors (SSE), and a lower value indicates a higher accuracy.





MAP MPW MAP MPW
Correct classification (overall) 94.1% 94.1% 68.3% 99.5% 99.5% 71.2%
Type I error rate: Pr(µj ∈ ∪c−1k=1Cˆk|µj ∈ C0) 4.0% 4.0% 5.0% 0.6% 0.6% 0.0%





t=1(µˆjt − µjt)2 18.5 18.5 54.1 4.3 4.3 38.5
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Table 2.5: Simulation results from section 2.4.2. The correct classification rates
is formed under different T and different effect sizes. For each simulation study,
N = 20, J = 35 and 200 simulated datasets were used. The accuracy of the estimated
trajectory is measured by the sum of squared errors.
T = 4 T = 5 T = 8
All Possible CPs All Possible CPs Selected CPs All Possible CPs Selected CPs
MAP MPW ORI MAP MPW MAP MPW ORI MAP MPW MAP MPW ORI
Correct classification (overall)
Large Effect Size 94.8% 94.9% 68.6% 91.4% 91.6% 95.0% 95.1% 77.4% 83.6% 84.3% 97.1% 97.3% 72.5%
Medium Effect Size 87.3% 87.5% 63.4% 80.9% 81.5% 89.0% 89.3% 73.1% 66.6% 68.1% 92.9% 93.5% 70.1%
Small Effect Size 71.5% 71.8% 41.6% 61.2% 63.3% 75.4% 76.0% 56.2% 45.8% 49.1% 82.6% 85.7% 64.6%
Type I Errors
Large Effect Size 0.6% 0.6% 0.0% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1%
Medium Effect Size 4.2% 4.2% 0.0% 1.3% 1.3% 1.3% 1.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1%
Small Effect Size 28.3% 28.3% 0.0% 14.3% 14.3% 14.3% 14.3% 0.0% 1.4% 1.4% 1.4% 1.4% 0.1%
Type II Error
Large Effect Size 0.0% 0.0% 1.9% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.2%
Medium Effect Size 1.0% 1.0% 12.9% 0.3% 0.3% 0.3% 0.3% 2.2% 0.0% 0.0% 0.0% 0.0% 0.2%
Small Effect Size 3.4% 3.4% 59.7% 1.8% 1.8% 1.8% 1.8% 29.2% 0.1% 0.1% 0.1% 0.1% 3.6%
Trajectory Accuracy
Large Effect Size 4.2 33.8 5.6 21.2 8.6 147.5
Medium Effect Size 4.2 13.7 5.6 9.9 8.5 42.6



























































































































































































































































Figure 2.1: Estimated trajectory with 95% credible interval (1st and 3rd columns)
and MPW estimators (2nd and 4th columns) for six representative phosphorylated
proteins. The gray lines represent the observed phosphorylation abundance of each
of the five patients. The boxes of MPW plots represent the posterior probabilities




























































































































































































































































































































(All profiles) (Selected profiles)
Figure 2.2: Boxplots of simulation results from Section 2.4.2. The correct classifica-
tion proportions shown are calculated based on 200 simulated datasets for each case.
For T = 4, all the possible candidate profiles are considered. For T = 5 and 8, the
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Large Effect Size Medium Effect Size Small Effect Size
Figure 2.3: Boxplots of sum of squared error (SSE) measuring the accuracy of tra-






































































































Figure 2.4: Q-Q plot and histogram of estimated residuals for ovarian tumor data.
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CHAPTER 3
INVESTIGATION OF DIFFERENT STATISTICAL METHODS
FOR ESTIMATING TREATMENT EFFECTS WHEN OUTCOME
VARIABLE IS ORDINAL AND CONFOUNDING EXISTS
3.1 Introduction
Ordinal categorical data has been quite commonly used in the clinical, social and
economic sciences (Agresti, 1996). For example, the commonly used Likert scale
in social survey study is an ordinal categorical variable with five different categories:
“Strongly disagree”, “Disagree”, “Neither agree nor disagree”, “Agree” and “Strongly
agree”, to capture the attitude of a subject to a certain statement (Likert, 1932). The
ordinal measured variables are often used as the primary outcome variable in clinical
trials. For example, the World Health Organization (WHO) uses an ordinal outcome
with four categories as the primary outcome to examine the efficacy of antimalarial
drugs for uncomplicated malaria: 1) ETF (early treatment failure); 2) LCF (late
clinical failure); 3) LPF (late parasitological failure) and; 4) ACPR (adequate clinical
and parasitological response) (Whegang et al., 2010). In our case study, we examine
whether physical activity contributes to diabetes status, with adjustment for subject’s
demographic information and dietary information. The outcome variable is classified
as diabetes, pre-diabetes, metabolic syndrome and normal. Studies with ordinal
outcome variable are common, and it is important to use the analytical methods
which control the unbalanced covariates and have good statistical properties.
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When the data arise from a randomized control trial, the subjects are randomly
assigned to different groups, say treatment and comparator groups. It is generally
assumed that there are no confounding covariates, either measured or unmeasured
(Austin, 2011). The commonly used methods for analyzing ordinal outcome vari-
able include parametric statistic method such as the cumulative logit/probit meth-
ods (Agresti, 1996) and non-parametric method, such as the Mann-Whitney U test
statistics (Mann and Whitney, 1947). The cumulative logit/probit models link the
cumulative probability and linear combination covariates with different intercepts for
different levels of responses (Agresti and Kateri, 2016). The parametric approach pro-
vides a powerful tool if the model is correctly specified. The non-parametric method
such as the Mann-Whitney U test statistic is also a powerful way to examine the treat-
ment effects for the ordinal outcomes when there is no confounding variables (Mann
and Whitney, 1947; Grissom, 1994). However, when the data arise from natural set-
tings such as electronic clinical records or registry data, the treatment selection may
depend on the patients’ own characteristics. The covariates between treatment and
comparator group may not be balanced. The statistical methods without considering
the selection bias may result in biased estimates for treatment effect. Historically, re-
gression adjustment methods such as cumulative logit/probit model is often used to
account for the difference in baseline characteristics between treatment and compara-
tor groups. Recently, the propensity score based methods, such as inverse probability
weighting, stratification and matching, have been widely used to reduce the impact
from the unbalanced confounding covariates in observational data (Austin, 2011; Ab-
dia et al., 2017). These propensity score based methods are free of outcome-specific
model and thus are robust in estimation of the treatment effect. These methods may
be applied to compare treatment effect for ordinal outcome variable by assigning nu-
meric scores to the ordinal outcomes, thus loosing the ordinal nature of the ordinal
variables.
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In the literature, the superiority score has been considered as a measure for
treatment effect for ordinal outcome (Klotz, 1966; Ryu and Agresti, 2008; Agresti
and Kateri, 2016). The Mann-Whiteney U test statistic can be considered as a
superiority score although the confounding variables are not adjusted (Mann and
Whiteny, 1947). In order to address the confounding covariates in the observational
data, Glen, Kong and Datta (2017) developed an adjusted U-statistic to test the
equality of distributions across multiple groups when the confounding covariates exist.
Agresti and Kateri (2016) presented probit/logit model based methods to estimate
the superiority score. However, the parametric models such as probit/logit models
are prone to provide biased estimates if the model is misspecified. On the other hand,
the propensity score based methods such as stratification, matching, and weighting
may provide excellent way to estimate treatment effect with control of confounding
variables. The propensity score is also called balance score and the propensity score
based methods usually do not assume outcome regression models. In this project,
we investigate the confounding-adjusted to estimate the superiority score for ordinal
outcomes with control of confounding covariates.
This chapter is organized as following: In Section 3.2, we investigate the sta-
tistical methods for assessing treatment effects for ordinal outcome when confounding
variables exist. These methods include the cumulative logit model, propensity score
based matching and stratification, and the adjusted U-statistic. In Section 3.3, sim-
ulation studies are carried out to compare the performance of these methods. In
Section 3.4, a case study using the National Health and Nutrition Examination Sur-
vey (NHANES) data is carried out to examine the causal effect of physical activities
on diabetes status with adjustment of demographic and dietary information. The last
section is devoted to a discussion.
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3.2 Statistical Method
Suppose N subjects are included in the sample, and Xi, Yi, Ti, respectively, denotes
a vector of p confounding variables, the ordinal outcome variable, and the treatment
assignment for ith subject in the study. Here Yi is an outcome variable with C ordinal
categories (i.e., Yi ∈ {1, 2, . . . , C}), and Ti takes 1 if the ith subject is assigned to
treatment group, and takes 0 if the ith subject is assigned to comparator group. For
notational convenience, numeric numbers are assigned to the outcome variable Yi to
keep the ordering but without numeric meanings. For the ith subject, there are two
potential outcomes: the potential outcome under treatment Y
(1)
i and the potential
outcome under comparator group Y
(0)
i . The observed outcome is:
Yi = TiY
(1)




i , if Ti = 0,
Y
(1)





i are ordinal categorical variables with C categories, a higher cat-
egory indicates a better outcome. Here we assume that all confounding variables
are observed, and the assumptions on overlap and strong ignorability (Rosenbanm
and Robin, 1983) hold. For ordinal outcome variable, the stochastic superiority
score (Klotz, 1966) measures if the outcome under treatment is stochastically larger












i ). Under the null hypothesis that there is no
treatment effect, the superiority score equals to 0.5. In the following subsection 3.2.1,
we investigate the parametric method to estimate the superiority score. On Section
3.2.2 we apply the propensity score-based matching and stratification to the superior-
ity score, and in Section 3.2.3 we apply the adjusted Mann Whitney U test statistics
to assess the superiority score when the confounding covariates exist.
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3.2.1 Parametric method for estimating superiority score
The ordinal logistic regression (OLR) is also known as the cumulative logit model. It
is a widely used method to estimate the treatment effect for ordinal outcome variable.
The OLR assumes that the effect of the treatment (or covariates) is identical for all
C − 1 cumulative logits and a single parameter is used to describe the treatment
effect when the model fits data well (Agresti, 1996). The OLR model uses a set of
dichotomized logistic models as follows:
log
P (Y ≤ k|X,T )
P (Y > k|X,T ) = αk −Xδ − τT,
where k = 2, . . . , C. The parameters (α1, . . . , αk, δ, τ) can be estimated based on the
maximum likelihood estimation. Hypothesis testing for treatment effect is conducted
by the Wald test for testing the hypothesis that H0 : τ = 0 vs. H1 : τ 6= 0. The
cumulative logit model uses the proportional odds structure to interpret the treatment
effects. However, the superiority score can be approximated from the maximum
likelihood estimate of τ (Agresti and Kateri, 2016):
















· σˆ2τ . The hypothesis testing for treatment effect is equivalent to test
H0 : γOLR = 0.5 vs. H1 : γOLR 6= 0.5. The test can be carried out using the Wald
statistic z = γˆOLR−0.5
σˆOLR
, where σˆ2OLR is the estimated variance for γˆOLR, and the p-value
is obtained from 2Φ(−|z|), where Φ is the cumulative density function of a standard
normal distribution.
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3.2.2 Propensity score based methods for estimating superiority score
The propensity score is the probability of receiving treatment conditional on observed
baseline covariates (Rosenbaum and Rubin, 1983), which can be written as:
ei(Xi) = Pr(Ti = 1|Xi),
where i = 1, . . . , N . Rosenbaum and Rubin (1983) proved that similar distributions
of propensity scores between treatment and comparator groups implies similar dis-
tributions of confounding covariates between treatment and comparator groups, thus
propensity score is also considered as a balancing score. The propensity score could
be estimated based on parametric model such as logistic regression model or machine
learning method such as generalized boosting method (Abdia et al., 2017). However,
in this project, the propensity score is estimated from the logistic regression model:
log
ei(Xi)
1− ei(Xi) = log
{
Pr[T = 1|Xi]
1− Pr[T = 1|Xi]
}
= Xiβ (3.1)
The estimate of β is obtained by using the maximum likelihood method. Two propen-
sity score based methods are considered: propensity score-based matching (PSM) and
propensity score-based stratification.
1. Propensity score-based matching
Propensity score-based matching could be implemented by first obtaining the coun-
terfactual outcomes via matched samples of the treated and comparative subjects,
and then estimating the treatment effect by averaging the subject-level treatment ef-
fects over the N subjects (Rosenbaum & Rubin, 1983, 1985). The steps to implement
propensity score-based matching are as follows:
Step 1: Calculate propensity score for each subject ei = Pr(Ti = 1|Xi), where i =
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1, . . . , N ;
Step 2: For ith subject, if Ti = 1, then Y
(1)
i is observed, and Y
(0)
i is estimated from
a subject j in the comparator group such that the propensity score ej is the
closest one to ei. Similarly, for a subject in comparator group (i.e., Ti = 0), Y
(0)
i
is observed, and the counterfactual outcome Y
(1)
i is estimated from a subject in
the treatment group whose propensity score is the closest one to ei;




i ) for i
th subject is thus able to be used to assess the




























































i ) (see Ap-
pendix 2 for the detailed derivation of σˆγ,Mat). The hypothesis test H0 : γMat =
0.5 vs. H1 : γMat 6= 0.5 is carried out by using the Wald test statistic z = γˆMat−0.5σˆγ,Mat
with p-value as 2Φ(−|z|), where Φ is the cumulative density function of a stan-
dard normal distribution.
2. Propensity score based stratification
The propensity score-based stratification methods is to divide subjects to several dif-
ferent strata based on their propensity scores. Within each stratum, the distributions
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of the covariates are considered similar for treated subjects and comparative subjects.
Thus, the treatment effect can be estimated within each stratum, and the treatment
effect over entire sample can be estimated by the average treatment effects across
different strata. The steps to carry out the propensity score-based stratification are
as follows:
Step 1: Estimate the propensity score eˆi = Pˆ (Ti = 1|Xi) for i = 1, . . . , N ;
Step 2: Rank the subjects with respect to their propensity scores, and then stratify all
subjects to S strata (usually S = 5) based on the quantile of the propensity
scores;
Step 3: Examine the covariate balance based on the absolute standardized mean dif-













p,s are the mean of pth covariate in the treatment group and
comparative group, respectively. sdp is the standard deviation of p
th covariate
in the entire sample, and ns is the sample size at the s
th stratum. The pth
covariate is considered to be balanced if ASMDp ≤ 0.2;
Step 4: Let Xunbal denote the unbalanced covariates identified from step 3. For sth
stratum, the treatment effect is estimated from the ordinal logistic regression:
log
P (Y ≤ k|Xunbal, T )
P (Y > k|Xunbal, T ) = αk −X
unbalδ − τsT,
the parameters (αk, δi, τs) are estimated by the maximum likelihood method
based on the stratum-specific data (Ys, Ts, X
unbal
s )(s = 1, . . . , 5). According to














Step 5: The overall superiority score is thus estimated by pooling all the stratum-specific





γˆs. The variance of the






Step 6: Hypothesis testing of H0 : γˆStrat = 0.5 vs. H0 : γˆStrat 6= 0.5 is carried out
by using the Wald test statistic z = γˆStrat−0.5
σˆγ,Strat
with p-value 2Φ(−|z|) as stated
before.
3.2.3 Adjusted Mann-Whitney U test statistic
The Mann-Whitney U statistic (Mann and Whitney, 1947) is powerful to examine
treatment effect between two groups when there is no confounding covariates. The









where n1 and n0 are the numbers of subjects in treatment and comparator groups,
respectively. When the Wilcoxon kernel K(Yi, Yj) = I[Yi > Yj] +
1
2
I[Yi = Yj] is used,
this U statistic naturally reflects the stochastic superiority score. If the distributions
of outcome under treatment and comparator conditions are identical and there is no
confounding covariates, the superiority score equals 0.5. However, when there are
confounding covariates, two sample U statistics may not be appropriate to assess the
treatment any more.
In the presence of confounding covariates X, Glen, Kong and Datta (2017)
proposed an adjusted form of the U-statistic using the inverse probability weighting
to weight each subject into its study population. The weights are calculated based
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on the propensity scores. That is, the weight for ith observation is calculated as




, if Ti = 1,
1
1−ei(Xi) , if Ti = 0.
(3.3)
Here, ei(Xi) is the propensity score estimated from Equation 3.1. The adjusted U-

















Here the Wilcox kernel K(Yi, Yj) is applied, and the weight for i
th subject w˜t(Xi, Ti; β̂)
is a normalized weight which is obtained from
w˜t(Xi, Ti; β̂) =
w(Xi, Ti; β̂)
Ŵt(β̂)
, for Ti = t.
Here, w(Xi, Ti; β̂) is calculated based on the propensity score in Equation 3.3 and






w(Xi, Ti; β̂) · I(Ti = t)
where t = 0, 1.
In Glen, Kong and Datta (2017), the asymptotic normality of the adjusted
U-statistics is given and a close form of the asymptotic variance is presented. The
hypothesis for testing H0 : γu = 0.5 vs. H1 : γu 6= 0.5 is thus able to be carried out.






where vˆ is the asymptotic variance of γu and is estimated from the observed data.
The detailed formula of vˆ can be found in Glen, Kong and Datta (2017).
3.3 Simulation Study
Simulation studies are carried out to compare the performance of different methods
presented in Section 3.2. An ordinal outcome with four levels (say, 1, 2, 3, 4) is
considered. It should be noticed that the numeric numbers assigned to the outcome
are only for notational convenience, and these numeric numbers do not bear numerical
meanings. The treatment assignment variable T takes values 0 and 1, where T = 1
indicates treated subjects and T = 0 indicates comparative subjects. Three different
covariates X = (X.1, X.2, X.3)
T are considered, where X.1 ∼ N(0, 1), X.2 = X∗.2 − 0.5,
where X∗.2 ∼ Bin(1, 0.5) and X.3 ∼ Uniform(−0.5, 0.5). The treatment assignment
T is generated based on the logistic regression model:
log P (T=1|X)
P (T=0|X) = Xβ.
The covariate parameter β is set as as β = (1, 1, 1). Two scenarios are considered in
the simulation study. Scenario 1 assumes that the underlying outcome variable follows
an ordinal logistic regression, and scenario 2 assumes that the outcome variable follows
a cumulative Box-Cox model (Guerrero and Johnson, 1982). Since the ordinal logistic
regression is powerful when the underlying model is correctly specified and is sensitive
when the model is misspecified, we expect the ordinal logistic regression model have
the best performance among all the methods under scenario 1 and this advantages
disappears when the underlying model is misspecified.
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3.3.1 Scenario 1: Outcome follows an ordinal logistic model
In this simulation scenario the outcome variable was generated based on the ordinal
logistic regression model:
log
P (Y ≤ k|X,T )
P (Y > k|X,T ) = αk +Xδ + τT
where k = 1, 2, 3. We set the intercepts (α1, α2, α3) = (−1.39,−0.85,−0.62) so that
the probability of occurrence for the first level of the outcome as 0.2, i.e., Pr(Y =
1) = 0.2, and the probabilities for the second to fourth levels are roughly set as 0.1,
0.05, and 0.65, respectively, to match the percentages of outcomes in the case study
presented in next section. The covariate effect parameter δ is assigned as δ = (1, 1, 1).
The treatment effect parameter τ is considered to have values from sequence 0 to 0.6
with 0.05 increment.
We generated 1000 simulated data for each τ , and each simulated data in-
cludes 5000 observations. All the methods presented in Section 3.2 were applied to
estimate the treatment effect. The average of the rejection of the hypothesis test at a
significance level 0.05 for the 1000 simulated data is calculated. For comparison con-
venience, the estimated treatment effect parameter in the ordinal logistic regression
model is transformed to the superiority score using the approximation from Agresti
and Kateri (2016). Under the null hypothesis that there is no treatment effect, the
sizes of all methods are reported in Table 3.1. Only the ordinal logistic regression
and the adjusted U statistic have the size close to 0.05. The propensity score-based
matching, stratification and the classical Mann-Whitney test all have sizes much
larger than 0.05, thus not suitable for estimating treatment effect. For power calcu-
lation, we only consider the methods with a size close to 0.05 as the valid approach.
Thus, only the ordinal logistic regression and the adjusted U statistic are included in
the power analysis.
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Figure 3.1 shows the power curves of the ordinal logistic regression and the ad-
justed U statistics based on the simulated datasets from the ordinal logistic regression
model. As expected, the ordinal logistic regression shows higher power than the ad-
justed Mann-Whitney U test statistics. Table 3.2 summarizes the simulation results
in this scenario. The true superiority score γ is calculated as the average of the 1000
estimated superiority scores based on the 1000 simulated data. The superiority score


















i are respectively the outcomes under control and treatment con-
ditions based on the underlying model. The approximated true superiority score is







absolute bias of the estimated superiority score from the ordinal logistic regression
is 0.035, while the estimated superiority score from the adjusted U-statistic is 0.013.
The larger bias from the ordinal logistic regression may be due to the approximation
procedure when we transform the treatment effect parameter τ to the superiority
score γ. Since the U-statistic is essentially testing the superiority score, it has less
bias than the OLR model.
3.3.2 Scenario 2: Outcome follows a mixture cumulative Box-Cox model
In practice, we usually do not have enough priori information and do not know the
underlying model. In order to examine the performance of each method when the
underlying model is unknown, we consider the simulation scenario 2 in which the
simulated outcome variable is based on the mixture of Box-Cox distribution functions.
Here Xi and Ti were generated as Scenario 1. However, the outcome variable Yi was
generated from a mixture distribution of the following form:
Yi = Ti · F1(Xi, Ti) + (1− Ti) · F0(Xi, Ti)
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where F1(X,T ) = F (αk + Xδ + τT ;λ), F0(X,T ) = F (αk + Xδ; ;λ), and F belongs




0, x < − 1
λ
, λ > 0
(1+λx)1/λ
(1+λx)1/λ+1
, 1 + λx > 0, λ 6= 0
1, x > − 1
λ
, λ < 0
In the simulation study, we set λ = 1 and set (α1, α2, α3) by calculating the prob-
abilities of occurrence at the four levels of the outcome as (0.2, 0.1, 0.05, 0.65) for
comparator group. The ordinal logistic regression model and the adjusted U-statistic
are included in the power analysis. The superiority score estimated by the ordinal
logistic regression model is approximated according to the transformation given by
Agresti and Kateri (2016).
Figure 3.2 shows the power curve of the ordinal logistic regression and the
adjusted U-statistic based on the simulated datasets from simulation Scenario 2. On
the contrary of Scenario 1, the adjusted U-statistic has a higher power than the ordinal
logistic regression when τ is small and the two methods are getting close when τ goes
large. However, in this scenario the test size of the ordinal logistic regression model
is 0.082 which is too liberal compared to 0.05. The simulation results in this scenario
is reported in Table 3.3. The true superiority score is calculated as described in
Section 3.3.1. The averaged absolute bias of the adjusted U-statistic is 0.012, which
is much lower than the bias based on OLR model of 0.069. Compared with the bias in
Scenario 1 where the underlying model is the OLR model, the bias of the OLR model
significantly increases when the underlying model is misspecified, while the adjusted
U-statistic keep a relatively small bias.
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3.4 NHANES data application
For illustration, we applied the adjusted U-statistic and the ordinal logistic regression
to estimate the treatment effect of physical activity on diabetic status with control
the confounding variables such as the sociodemographic characters and dietary infor-
mation based on the National Health and Nutrition Examination Survey (NHANES)
datasets.
The NHANES is a nationally survey conducted by the Centers for Disease Con-
trol and Prevention’s National Center for Health Statistics (CDC-NCHS). NHANES
collects both nutrition status and health conditions for the U.S. population. This
study uses two NHANES datasets (2011-2012 and 2013-2014) in the analysis. The
study population includes 7876 subjects from age 20 to 79 with complete 24-hour
dietary recall data, complete laboratory data for plasma fasting glucose, glycohe-
moglobin, cholesterol and triglycerides, complete examination data for body measure
and blood pressure, and complete questionnaire data for diabetes and physical activ-
ities.
The outcome variable in this study is defined as different status of diabetes
and it is categorized to four levels: diabetes, pre-diabetes, metabolic syndrome and
normal. Sociodemographic characteristics include gender, age, race, education and
income. The dietary information of NHANES participants are collected by two 24-
hour dietary recall interviews. The data of total nutrients intakes on the second time
interviews are used in this study. 65 nutrients variables are included in the analysis.
Physical activities is considered as the “treatment” variable and it is first categorized
to three groups: no exercise, moderate exercise and vigorous exercise. However, we
further categorize the physical activity into two leverls: subjects who have neither
vigorous exercise nor moderate exercise are treated as no exercise; vigorous exercise
and moderate exercise are combined to one group as having exercise in the analysis.
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Principal component analysis is performed to summarize the dietary infor-
mation and reduce the dimension of the dietary data. Components that had an
eigenvalue of less than 1.0 (Kaiser, 1960) and accounted for less than 1% of variance
were excluded. In the analysis, 65 variables were reduced to 13 principal components.
Factor loadings with absolute values greater than 0.2 are considered. Each of the
principal component is labeled by the nutrition variable with highest loadings. The
13 principal components are labeled as energy, beta carotene, long chain fatty acid,
vitamin K, vitamin D, cholesterol, moisture, caffeine (negative), caffeine (positive),
total sugar, short chain fatty acid, beta cryptoxanthin and alcohol.
Using the adjusted U statistics, the estimated superiority score is γˆu = 0.516
(p = 0.011), which indicates that physical activity has significant protective effects on
diabetes. The ordinal logistic regression reports the estimates of treatment parameter
τˆ = −0.156 (p = 0.010), and the approximated superiority score is γˆOLR = 0.528,
which is similar to the results based on the adjusted U statistic.
The superiority measures γˆ has the interpretation that at any particular values
for nutrition intakes, individuals with physical activities have approximately 52%
chance (51.6% based on the adjusted U-statistic and 52.8% based on the OLR model)
to have better diabetes status than the ones without physical activities.
3.5 Discussion and Conclusion
In this project, the causal parameter of the stochastic superiority score is consid-
ered to estimate the treatment effect for the ordinal outcomes. We investigated and
compared the performance of different methods for estimating the treatment effect
for the ordinal outcomes with control of the confounding covariates, including the
ordinal logistic regression, the adjusted U-statistic, and the propensity score based
stratification and matching. The power analyses in the simulation studies show that
the adjusted U-statistic is more powerful and robust to estimate the superiority score
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for the ordinal outcome.
The superiority score and its slight variation have also been studied under
different experimental conditions for ordinal outcomes. For example, Chen (2009)
considers to assess the treatment effect for the ordinal outcome when the noncompli-
ance to assigned treatment exists. The procedure provides and estimates the form of
the superiority score based on a function of the multinomial distributions of compliers
to treatment assignments using likelihood method. Some other causal parameters are
also proposed in the literatures for studying the treatment effect when the outcome is
ordinal. Huang et al. (2017) proposes a plug-in estimator of the fraction who benefits
when the outcome is ordinal based on the marginal distribution of the potential out-
comes. The fraction who benefit is defined as the proportion of the population whose
potential outcome in treatment group is better than the potential outcome in control
groups, that is, Pr(YT > Yc), where YT and Yc are the potential outcomes for treated
subjects and untreated subjects, respectively. Lu et al. (2016) considers two causal
parameters, the probabilities that the treatment is beneficial and strictly beneficial
for the subjects. These two estimators can actually be applied for any outcomes but
especially for the ordinal outcomes. Lu et al. (2016) provides the sharp bounds of
the two parameters using the marginal distributions of the potential outcomes free
from the joint distribution assumption of the potential outcomes.
The superiority of a particular method may depend on the data structure.
When the data satisfies the proportional odds assumption, the ordinal logistic regres-
sion is no doubt a powerful way to estimate the treatment effect for the ordinal out-
comes. However, when the model is misspecified, the ordinal logistic regression lacks
robustness and may result in serious biased estimation. The adjusted U-statistics is a
free of outcome-regression model and thus has higher robustness than the parametric
approaches when the underlying model is unknown, which is the most commonly sit-
uation in practice. Since the U-statistic is adjusted by individual reweighting of the
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data based on the propensity score, it is able to control the impact of the confounding
covariates.
3.6 Tables and Figures
Table 3.1: Sizes of the tests based on different methods for simulated data sets gen-





Unadj. U Statistics 1.000
Adj. U Statistics 0.048
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Table 3.2: Summarized simulation results for Scenario 1, where outcome was gener-














0.000 0.500 0.500 0.501 1.178 1.204 0.500 0.741 0.743
0.050 0.497 0.491 0.491 1.208 1.199 0.495 0.761 0.748
0.100 0.494 0.482 0.482 1.183 1.193 0.490 0.736 0.751
0.150 0.491 0.474 0.473 1.174 1.187 0.485 0.741 0.753
0.200 0.488 0.465 0.465 1.147 1.180 0.480 0.740 0.757
0.250 0.485 0.456 0.456 1.175 1.173 0.474 0.774 0.760
0.300 0.482 0.447 0.447 1.137 1.165 0.469 0.760 0.763
0.350 0.479 0.438 0.438 1.167 1.157 0.464 0.783 0.766
0.400 0.476 0.430 0.430 1.158 1.149 0.459 0.784 0.768
0.450 0.473 0.421 0.421 1.134 1.141 0.453 0.774 0.772
0.500 0.470 0.413 0.413 1.111 1.131 0.448 0.760 0.775
0.550 0.467 0.404 0.404 1.094 1.121 0.443 0.754 0.777
0.600 0.464 0.395 0.396 1.098 1.112 0.437 0.780 0.779
Table 3.3: Summarized simulation results for Scenario 2, where the outcome variable
was generated from a mixture of Box-Cox distributions.
τ True γ










0.000 0.500 0.492 1.358 1.379 0.500 0.626 0.639
0.050 0.503 0.506 1.387 1.392 0.505 0.623 0.636
0.100 0.507 0.522 1.409 1.404 0.511 0.628 0.633
0.150 0.510 0.537 1.469 1.414 0.516 0.645 0.631
0.200 0.514 0.553 1.453 1.422 0.522 0.620 0.629
0.250 0.517 0.570 1.499 1.427 0.527 0.644 0.626
0.300 0.521 0.587 1.445 1.430 0.533 0.609 0.624
0.350 0.524 0.603 1.523 1.431 0.538 0.640 0.623
0.400 0.528 0.621 1.509 1.428 0.543 0.627 0.621
0.450 0.531 0.638 1.485 1.423 0.548 0.632 0.619
0.500 0.534 0.655 1.448 1.416 0.553 0.625 0.618
0.550 0.537 0.673 1.485 1.403 0.558 0.633 0.617
0.600 0.541 0.690 1.432 1.388 0.563 0.631 0.616
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Figure 3.1: Power curves for different methods with data generated from ordinal
logistic regression models in simulation Scenario 1.
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CAUSAL ANALYSIS OF DIETARY INFORMATION AND
PHYSICAL ACTIVITY IN TYPE 2 DIABETES BY GENDER IN
WHITE, AFRICAN AMERICAN AND MEXICAN AMERICAN:
NATIONAL HEALTH AND NUTRITION EXAMINATION
SURVEYS 2011-2014
4.1 Introduction
Type 2 diabetes mellitus (T2DM) has become a major public health problem world-
wide and one of the major causes of mortality in the United States outstripping
cancer, HIV/AIDS, and cardiovascular disease. Enormous economic and psychoso-
cial consequences are also associated with T2DM (Menke et al., 2015, Zimmet et
al., 2016, American Diabetes Association, 2013 and Wang et al., 2016). The com-
plications leaded by diabetes occur in many parts of body and increase the risk of
ultimate death. Not only to the individual and their family, diabetes will also result
in huge economic burden on the health system and nation. Globally, around 422
million adults were suffering from diabetes in 2014, which is 8.4% of the adult pop-
ulation (World Health Organization, 2016). In the U.S., the prevalence of diabetes
has risen rapidly during the recent decades. In 1995, 3.3% of the U.S. population
were diagnosed with diabetes and the number increased to 5.61% in 2005 and then
7.14% in 2015. In 2015, 30.3 million people in the U.S. have diabetes (9.4% of the
U.S. population) of which 23.1 million has already been diagnosed as diabetes but
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7.2 million has not been aware of or reported having diabetes (Centers for Disease
Control and Prevention, 2017).
An analysis is performed by Menke et al. (2012) using the National Health
and Nutrition Examination Survey (NHANES) data, which shows that the total un-
adjusted prevalence (diagnosed plus undiagnosed) of diabetes was 12.3% in the US
population, and in 25.2% of those diabetes were undiagnosed (Menke et al., 2015).
Differences of diabetes distributions were also observed in different ethnicity groups.
The study of Menke et al. (2015) shows that the prevalence is much higher in non-
Hispanic black (19.1%) and in Mexican American (14.5%) compared to the prevalence
of total diabetes in non-Hispanic white (10.1%).
Among all the people with diabetes around the world, T2DM comprises ap-
proximately 90% of diabetic cases, and type 1 diabetes only accounts for about 10%
of cases of diabetes (World Health Organization, 1999). However, type 1 diabetes is
a different disease process characterized by total inability of the pancreas to produce
insulin. It is important to analyze the relationship between diet and type 2 diabetes
because food intake is the crucial variable in the control of T2DM. The second im-
portant component of T2DM control is physical activity. These two components are
two of the three major foundations of diabetes therapies, the third being medication.
The NHANES continuous database includes physical activity and detailed analysis
of dietary components. These data have not been previously analyzed and may offer
important insights into dietary variability, physical activity and the management of
T2DM. Multivariate causal model analysis of the combination of the dietary data,
measures of physical activity, BMI, across three major US ethnic groups may reveal
variation in these variables that underlies major features in type 2 diabetes. Such
information may contribute to a better understanding of type 2 diabetes variation
among ethnic groups, and a better understanding of type 2 diabetes between female
and male within each ethnic groups.
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The analytical model is path analysis (i.e., causal structural equations) to ex-
plore the relationships between variables that are clearly causal and outcomes (e.g.,
type 2 diabetes). Path analysis proposed by Wright (1921) is a method used to
determine whether a multivariate non-experimental dataset fits a particular causal
model or not. Although path analysis is not applied to establish the causal relation-
ship between variables, it is very powerful to examine and compare different complex
hypothesis causal models and to find the most consistent one to the data (Streiner,
2005). As a result, the causal importance of independent variables on the outcomes
can be quantitatively estimated.
In the present investigation, we apply path analysisi to examine the associ-
ation between physical activity and diet on diabetes outcome using the NHANES
data (2011-2014). Included T2DM patients are those who are taking only oral hy-
poglycemic agents (biguanides, sulfonylureas, thiazolidinedione-TZDs). Nelson et al.
(2002) described diet and physical activity situations of U.S. adults with T2DM from
NHANES III. However, analyses of the NHANES dietary data in a causal path model
that includes physical activity and predicts HbA1c has not been conducted previously.
The objective of this investigation is to analyze the causal paths that predict HbA1c
using data on demographics, dietary, BMI, physical activity.
4.2 Method
4.2.1 Data and Materials
NHANES 2011-2014 datasets are analyzed in this study. NHANES is a nationally sur-
vey conducted by the National Center for Health Statistics in the Centers for Disease
Control and Prevention (CDC-NCHS). It collects both of nutrition status and health
conditions for the U.S. population. This project combines two NHANES datasets of
study circles 2011-2012 and 2013-2014 in the analysis. The dietary information of
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NHANES participants are collected by two 24-hour dietary recall interviews. The
data of total nutrients intakes on the second time interviews are used in this study.
Totally, 65 nutrition intake variables are extracted from dietary dataset and
used to measure dietary information of subjects in this project. Subjects from 20
to 79 years old in non-Hispanic white, non-Hispanic black and Mexican American
are included in the study. Two dummy variables of non-Hispanic black and Mexican
American are used to stand for the three different ethnicities in the study population.
All the subjects included have a full record for demographic characteristics, physical
activity, BMI, HbA1c and all 65 nutrition intakes.
The variable of physical activity is defined using the physical activity question-
naire data. Subjects who reports either vigorous work activities or vigorous recre-
ational activities are defined as vigorous activity. Subjects who have moderate work
activities or moderate recreational activities are defined as moderate activity. The
final variable of physical activity used in the analysis is a dummy variable with 1
indicates subjects who have either vigorous activities or moderate activities.
Education includes five levels: less than 9th grade, 9-11th grade (including 12th
grade with no diploma), high school graduate/general educational development or
equivalent, some college or associate degree, and college graduate or above. Education
is treated as a continuous variable by assigning scores 1 to 5 to the five levels in order.
Higher score indicates higher education level.
Social economics status (SES) is measured by family monthly poverty level.
It is categorized to 3 levels based on monthly poverty level index: ≤ 1.30, between
1.30 and 1.85, and > 1.85. The monthly poverty level index is defined as the ratio
of monthly family income to the Department of Health and Human Services (HHS)
poverty guidelines specific to family size. Numeric scores 1 to 3 are assigned to the
three levels of SES. SES is treated as a continuous variable in the analysis where a
higher score indicates a higher income.
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4.2.2 Statistical Analysis
Path analysis is applied to determine the causal relationships between demographic
variables, physical activity and dietary information to the outcome variable which is
the diabetes status. Glycohemoglobin (HbA1c) level is used to measure the diabetes
status. Figure 1 shows the hypothesis causal model considered in this study. In the
assumed path diagram, Xs indicate the demographic variables or physical activity, and
Ns indicate the dietary information. For illustration, only two demographic variables
and two nutrition intake variables are drawn in Figure 4.1. The demographic variables
or physical activities (Xs) are considered as exogenous variables, where the variance
of these variables are not explained by the variables inside the assumed causal model.
The dietary variables (Ns), BMI and HbA1c are the endogenous variables where
part of their variances are explained by the other variables inside the causal model.
In the path diagram, double headed arrow indicates the correlation between two
variables which indicates that we assume there is no causal relationship between the
two variables but there is correlation between them. The single headed arrow indicates
the directional causal paths from one variable to another one. For all endogenous
variables, part of their variance are also possibly explained by the extraneous variables
(es), which are the variables outside the causal models.
In the hypothetical causal model, there are four different paths that the de-
mographic variables or physical activity can influence the outcome: (1) direct effect:
X → HbA1c; (2) indirect effect through dietary information: X → N → HbA1c; (3)
indirect effect through BMI: X → BMI → HbA1c; and (4) indirect effect through
dietary information and BMI: X → N → BMI → HbA1c. The total causal effects
of demographic variables or physical activity on the outcome will be the sum of the
effects from all the paths mentioned above.
All the data for continuous variables are standardized. A multivariate linear
regression by regressing the outcome on all the other variables (demographic variables,
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physical activity, dietary variables and BMI) is performed to identify the important
variables in the path analysis. In the path analysis, each direct path is examined
based on the Bonferroni adjusted p-values. Only significant paths are retained and
reported in later path analysis results. An indirect paths is considered significant if
the product of the path coefficients is greater than 0.1.
Path analysis is performed for the entire population first. The descriptive
statistics of all the variables included in the path analysis for the entire population
are reported in Table 4.1. In order to study the causality for each homogeneous
group, path analysis is also performed for each gender-specific subpopulation and
gender-ethnicity-specific subpopulation.
4.3 Results
2832 subjects are included in the analysis with age 48.1 ± 16.2 (mean±sd). 52.7%
of the participants are female, and 47.3% are male. The study population includes
three major ethnicities in the U.S.: 1573 (55.5%) non-Hispanic white, 814 (28.7%)
non-Hispanic Black and 445 (15.7%) Mexican Americans. 7 dietary variables are sig-
nificant from the multivariate linear regression of regressing HbA1c on all demographic
variables, physical activity, 65 dietary variables and BMI. The 7 significant dietary
variables are: protein, carbohydrate, total sugars, total fat, magnesium, moisture and
butanoic fatty acid, which are included in the path analysis. Table 4.1 reports the
descriptive statistics for the variables included in the path analysis by gender and
race.
Figure 4.2 shows the path diagram with significant paths for the entire study
population. Table 4.2 reports the estimated path coefficients of significant paths.
From Table 4.2, physical activity does not show significant direct causal effect on
HbA1c. However, physical activity indirectly affects HbA1c via BMI and magnesium
intake. Via BMI, physical activity has a negative effect of -0.043 on HbA1c, and via
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magnesium intake, the effect is -0.026. Physical activity thus has a negative causal
effect of -0.069 on HbA1c in total.
Age positively affects HbA1c with a total causal effect of 0.298, which includes
a direct effect of 0.282 and an indirect effect of 0.016 via BMI. Similarly, education
affects HbA1c through a direct effect of -0.087 and an indirect effect of -0.019 via
magnesium intake, which lead to a total causal effect of -0.106 on HbA1c. Social
economics status does not show any significant causal effect on HbA1c.
For the 7 dietary variables included in the path analysis, butanoic fatty acid
does not have significant causal relationship with HbA1c. Total sugars intake has
a direct negative effect of -0.081 on HbA1c. Protein, carbohydrate, total fat and
moisture all have an indirect effect on HbA1c through BMI, which are 0.030, -0.021,
0.024 and 0.026, respectively. Magnesium intake shows a relatively strong causal
effect of -0.161 on HbA1c, which includes a direct effect of -0.127 and an indirect
effect of -0.034 via BMI.
Gender plays an important role in the causal model. Although gender does
not affect HbA1c directly, gender has several different paths that indirectly affects
HbA1c through one or two mediate variables. The estimated effect of each path are
reported in Table 2. In summery, gender has a total causal effect of -0.107 on HbA1c
which indicates that female has higher HbA1c than male. In order to investigate
the difference in the causal structure for between male and female, a separate path
analysis is performed for male and female, respectively.
Table 4.3 and Table 4.4 report the estimated causal effects of each independent
variable on the outcome variable HbA1c for male and female, respectively. Figure 4.3
and Figure 4.3 are the path diagram with only significant paths for male and female,
respectively. Physical activity shows similar causal effects on HbA1c for both male
(-0.057) and female (-0.051). However, for male, physical activity affects HbA1c via
BMI, while for female, physical activity affects HbA1c through magnesium intake. For
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female, age has a direct effect of 0.293 on HbA1c. For male, age has a direct effects
of 0.245 on HbA1c, and also affects HbA1c via energy and carbohydrate intake with
a total effect of 0.295. Education and SES do not show significant causal effects on
HbA1c for male. However, SES has an indirect causal effect of -0.115 on HbA1c
through BMI, which indicates that female with a lower income is believed to have a
higher BMI, and then result in a higher HbA1c value.
Two dummy variables of Mexican American and Non-Hispanic black are used
in the analysis and Non-Hispanic White is used as a reference. According to the
results in Table 4.2, Mexican American shows a negative causal effect of -0.065 on
HbA1c, which comes from the indirect paths via magnesium intake. Non-Hispanic
black has a strong positive causal effect of 0.347 on HbA1c, which includes a direct
effect of 0.302 and an indirect effect of 0.045 through BMI. In order to study the
specific causal relationship for each homogeneous ethnicity group, separated path
analysis are constructed for each gender-race-specific subpopulation.
Table 4.5 reports the significant paths for Mexican American male and female.
Dietary variables in the path analysis for Mexican American male include total fat,
added vitamin B12, vitamin K and caffeine. Dietary variables included in the path
analysis for Mexican American female are: total sugars, total monounsaturated fatty
acids, lutein and zeaxanthin, magnesium, iron and selenium. Age has strong positive
direct effect of 0.385 for Mexican American male, compared to 0.322 for Mexican
American female. Education and SES do not show any significant causal effects on
HbA1c for Mexican American.
Table 4.6 reports the estimated causal effects of significant paths for non-
Hispanic black by gender. Since no dietary variables are significant in the multivariate
linear regression for non-Hispanic black male, the following path analysis is skipped.
For non-Hispanic black female, physical activity shows a significant effect of -0.073 on
HbA1c through magnesium intakes. Similarly, education also has a negative causal
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effect of -0.052 on HbA1c through magnesium intakes. Age shows a strong positive
direct effect of 0.340 on HbA1c for non-Hispanic black female. (See Table 4.6 for
estimated path coefficients and Figure 4.6 for the path diagram).
Table 4.7 reports the estimates of significant path coefficients for non-Hispanic
white by gender. For non-Hispanic white male, age has positive causal effect of 0.265
on HbA1c, which includes a direct effect of 0.227 and indirect effects through energy
intake, carbohydrate intake and BMI. For non-Hispanic white female, age only has
a direct effect of 0.273 on HbA1c. For white male, education shows a direct effect
of -0.115 on HbA1c, while education is not significant for white female. However,
physical activity causes reduction in BMI and hence results in an indirect effect on
HbA1c of -0.081 for white female, while no significant effect of physical activity is
observed for white male. Figures 4.7 and 4.8 are the path diagrams for non-Hispanic
white male and female, respectively.
4.4 Discussion and Conclusion
In our study, the variation among different homogeneous groups are observed. Based
on our analysis, males tend to have lower HbA1c level than females based on our
analysis (-0.107, see Table 4.2). The total effect of physical activity on HbA1c is
desired from several indirect paths through nutrition intake. Males have much higher
intakes of all nutrition components than females, especially for protein (0.557) and
total fat (0.447). Compared to males, females have a relatively higher BMI (-0.248),
apparently causing a higher HbA1c. This result can be explained by the different
body composition of female and male. The path model is also observed to vary
across different ethnicities is also observed. Consistent with the prevalence of T2DM
in the U.S. population, non-Hispanic blacks have a higher risk of T2DM compared to
non-Hispanic whites. However, Mexican-Americans have a lower risk of T2DM than
non-Hispanic white. Higher intake of magnesium in white, which is known to lead to
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lower HbA1c values, is one of the significant differences.
Total sugar intake is observed to have a direct beneficial effect (-0.081, see Table
4.2) of decreasing HbA1c. Our finding supports the negative association between
total sugar intake and the risk of T2DM observed from a prospective study of 36,787
non-diabetic men and women (Hodge et al., 2004). The observed effects of total
sugar intake on T2DM from current published studies are inconsistent. Janket et
al. (2003) reported that no definitive evidence was observed that total sugars intake
is associated with developing T2DM based on a prospective study of 38,480 initially
healthy postmenopausal women. Tsilas et al. (2017) performed a systematical review
and meta analysis of prospective cohort studies to assess the association between the
intakes of total sugar or certain sugar type and the risk of T2DM. No significant
effect was observed of the intakes of total sugars and fructose on the risk of T2DM.
However, intake of sucrose was observed to have beneficial effect of decreasing T2DM.
Higher intake of total fat is observed to result in higher HbA1c through BMI
(0.024, see Table 4.2) in our study. This strong positive effect is particularly observed
in males (0.342, see Table 4.3), while for females, total fat intake is not significant on
HbA1c. Our result supports the conclusion of a prospective study of 42,504 male that
total fat intake was associated with a higher risk of T2DM but was not independent
of BMI in men (Van Dam et al., 2002). Also, no association was observed between
total fat intake and the risk of T2DM in women based on another prospective study of
84,204 women (Salmeron et al., 2001). Although some studies reported no association
between total fat intake and T2DM, significant relationship of the intakes of certain
types of fat and T2DM were observed. Harding et al. (2004) conducted a prospective
study of 23,631 Caucasian men and women aged 40-78 years, and there study didn’t
find significant association between total fat intake and the risk of T2DM. However,
a higher ratio of dietary polyunsaturated fat to saturated fat was observed to have a
protective effect on the development of T2DM.
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In our study, intake of protein is found to have a positive effect on HbA1c
through BMI (0.03, see Table 4.2). This result is consistent with some previous
studies that intake of protein has positive relationship with the risk of T2DM (Malik
et al., 2016; Sluijs et al., 2010; Van Nielen et al., 2014; Shang et al., 2016). Based
on three large prospective cohort studies of US adults, Malik et al. (2016) also found
a positive association between total protein intake and the risk of T2DM, and this
positive association is observed to be largely due to the intake of animal protein. In
the contrast, they also observed a protective effect of intake of vegetable protein on
T2DM.
In our study, no direct effect of total carbohydrate intake on HbA1c is ob-
served. However, dietary carbohydrate is negatively associated with BMI (-0.10),
which further results in a lower effect (-0.021) on decreasing HbA1c (see Table 4.2).
Our finding of the negative effect of carbohydrate intake on BMI is consistent with
the literatures (Hodge et al., 2004). Merchant et al. (2009) reported that a low-
carbohydrate diet is associated with higher probability of being overweight or obese
among healthy adults. The association between carbohydrate intake and BMI or
T2DM is controversial. Total dietary carbohydrate intake does not have significant
effect on the risk of T2DM according to some researches. However, certain patterns of
carbohydrate consumption (e.g., percentage of total energy) have a significant effect
on BMI and HbA1c. Ma et al. (2005) reported no significant relationship between
total daily carbohydrate intake and BMI among 572 healthy adults in central Mas-
sachusetts. However, the percentages of calories from carbohydrate had a significant
positive effect on BMI. Meyer et al. (2000) reported that the total carbohydrate in-
take is associated with the risk of T2DM in a prospective cohort study of 35,988 Iowa
women (55-69 years old) who were initially free of diabetes. However, certain types
of carbohydrate, such as grains (especially whole grains), has significant protective
effect of T2DM (Meyer et al., 2000). Haimoto et al. (2008) compared the long-term
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effect of a carbohydrate-reduced diet to a conventional diet in T2DM patients in a
2-year follow up study. The conventional diet restricted energy intake by reducing
fat for T2DM, while the carbohydrate-reduced diet asked T2DM patients limiting
carbohydrate-rich foods to once or twice a day. They found that the carbohydrate-
reduced diet caused decreases in both HbA1c and BMI. Their results suggested that
restricting carbohydrate intake is more beneficial than restricting fat consumption in
the management of T2DM.
Our study reveal the importance of magnesium intake in decreasing the risk
of T2DM. Compared to the effect of protein, carbohydrate, total fat and moisture,
magnesium intake has a stronger effect on HbA1c. Higher intake of magnesium has a
better beneficial effect on decreasing BMI and HbA1c, further on decreasing the risk
of T2DM. This finding is consistent with several other publications. Van Dam et al.
(2006) found that high dietary magnesium intake is associated with a substantially
lower risk of T2DM in U.S. black women in an 8-year prospective study of 41,186
U.S. black women. This result is consistent with ours that magnesium intake has a
strong causal effect (-0.246) on decreasing HbA1c in non-Hispanic black females. The
association between magnesium intake and fasting insulin concentrations are investi-
gated among middle-aged women who were not diabetic (Fang et al., 2003). Higher
magnesium intake is associated with lower fasting insulin concentrations, indicating
higher insulin sensitivity. Lopez-Ridaura et al. (2004) observed a consistent inverse
association between magnesium intake and risk of T2DM based on two large prospec-
tive studies in men and women. Across all the subgroup study, classified by different
BMI, physical activity and family diabetes history, magnesium remained significant
protection against T2DM. A meta-analysis of prospective cohort studies (Dong et
al., 2011) supported the observations that magnesium intake has a significant in-
verse association with the risk of T2DM. Resnick et al. (1993) suggested that both
extracellular and intracellular magnesium deficiency is associated with chronic mild
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T2DM. A high prevalence of hypomagnesaemia and lower intracellular magnesium
concentrations were found in diabetic subjects (Barbagal and Dominguez, 2006). Hy-
pomagnesemia occurs among 13.5% to 47.7% among patients with T2DM compared
with 2.5% to 15% among the subjects without T2DM (Pham et al., 2007). Magne-
sium has a complex relationship with insulin and glucose. On one hand, insulin is a
hormone that regulates magnesium metabolism, and glucose is a physiologic deter-
minant of cellular magnesium (Barbagal and Dominguez, 2007). On the other hand,
magnesium is also a major determinant of insulin and glucose metabolism. It serves
as a a modulator of insulin action and insulin sensitivity (Barbagal and Dominguez,
2007).
Another significant dietary component based on our analysis is moisture intake.
It includes moisture present in all foods, beverages, and water consumed as a beverage.
A positive association between moisture intake and HbA1c is observed through BMI
(0.026, see Table 4.2). Our results supports the finding of Kant et al. (2009) that total
water intake was associated with increased BMI. However, the association between
total moisture intake and the risk of T2DM has not well-investigated because of the
limited research, but the effects of various contributors to the total moisture intake
on the risk of T2BM was examined in several studies. Roussel et al. (2011) reported
a negative association between daily water intake and the risk of hyperglycemia based
on a 9-year follow up study of 3,615 middle-aged French men and women. However,
Pan et al. (2012) did not observe significant association between the plain water intake
and the risk of T2DM based on a prospective study of 82,902 young and middle-aged
women. In a cross-sectional study of sample size 138, Carroll et al. (2015) found that
higher plain-water intake is associated with a lower T2DM risk score.
The relationship between BMI and T2DM has been well-investigated. BMI
is an crucial and modifiable risk factor for T2DM. Nguyen et al.(2010) showed a
clear association between BMI and diabetes in a large, representative sample of the
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US population using NHANES 1999-2006 data. The lowest prevalence of diabetes
was found in the normal weight group (BMI < 25.0), and the prevalence of diabetes
increased as obesity class increases. Our study shows strong direct effect of BMI
on increasing HbA1c across all subgroups. Some dietary intake factors(i.e., protein,
carbohydrate, total fat and moisture) affect HbA1c only through BMI (see Table
4.2 and Figure 4.2). In order to have a clear understanding of causal paths through
BMI, we also performed a path analysis that use two dummy variables (overweight
with BMI between 25 and 30 and obesity with BMI ≥ 30)) in the analysis instead
of the continuous variable BMI. The results indicate that all the causal effects on
HbA1c from independent variables through BMI are changed through obesity (see
Figure 4.9 for the path diagram). These findings agree with the previously published
results (Nguyen et al., 2010) that the prevalence of diabetes increases with increased
obesity. The indirect effect from physical activity through obesity to HbA1c but not
overweight also supports the finding that physical activity has a protective effect in
subjects with high BMI (Hu, et al., 2004).
This project performed multivariate causal analysis to investigate the causal
relationship between the two important components in T2DM therapies using the
NHANES 2011-2014 continuous database: physical activity and dietary. Analysis
was also carried out in homogeneous subgroups. Variability in causal structures are
observed across different subgroups, while the causal importance of some components
such as the intake of magnesium stay relatively stable. Magnesium intake is a signifi-
cant protective factor, decreasing HbA1c, especially in females. Our work provides an
insight understanding in possible causal association between physical activity, dietary
components and diabetes status (i.e., HbA1c).































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4.2: Significant paths and summarized causal effects for each variable in the
path analysis for the entire population. Dietary variables in the path analysis include
protein, total sugars, total fat, magnesium, moisture and butanoic fatty acid. Only
significant direct effects and indirect effects no less than 0.01 are reported in the table.
For indirect effects, intermediate path coefficients are reported in 2nd to 4th columns






Physical Activity ->BMI -0.202
Physical Activity ->Magnesium 0.205
Physical Activity ->Moisture 0.184
Physical Activity ->BMI ->HbA1c -0.202 0.214 -0.043
Physical Activity ->Magnesium ->HbA1c 0.205 -0.127 -0.026






Age ->Total Sugars -0.11
Age ->Total Fat -0.084
Age ->SFA 40 Butanoic -0.085
Age ->BMI ->HbA1c 0.074 0.214 0.016






Education ->Magnesium ->HbA1c 0.152 -0.127 -0.019





Gender ->Total Sugars 0.27
Gender ->Total Fat 0.447
Gender ->Magnesium 0.373
Gender ->Moisture 0.261
Gender ->SFA 40 Butanoic 0.205
Gender ->BMI ->HbA1c -0.248 0.214 -0.053
Gender ->Total Sugars ->HbA1c 0.27 -0.081 -0.022
Gender ->Magnesium ->HbA1c 0.373 -0.127 -0.047
Gender ->Protein ->BMI ->HbA1c 0.557 0.139 0.214 0.017
Gender ->Total Fat ->BMI ->HbA1c 0.447 0.111 0.214 0.011
Gender ->Magnesium ->BMI ->HbA1c 0.373 -0.161 0.214 -0.013




MexA ->Magnesium ->HbA1c 0.401 -0.127 -0.051
MexA ->Magnesium ->BMI ->HbA1c 0.401 -0.161 0.214 -0.014





NHB ->SFA 40 Butanoic -0.266
NHB ->BMI ->HbA1c 0.209 0.214 0.045
Total effects on HbA1c 0.347
Total Sugars
Total Sugars ->HbA1c -0.081
Protein
Protein ->BMI 0.139
Protein ->BMI ->HbA1c 0.139 0.214 0.030
Total effects on HbA1c 0.030
Carbohydrate
Carbohydrate ->BMI -0.1
Carbohydrate ->BMI ->HbA1c -0.100 0.214 -0.021
Total effects on HbA1c -0.021
Total Fat
Total Fat ->BMI 0.111
Total Fat ->BMI ->HbA1c 0.111 0.214 0.024




Magnesium ->BMI ->HbA1c -0.161 0.214 -0.034
Total effects on HbA1c -0.161
Moisture
Moisture ->BMI 0.121
Moisture ->BMI ->HbA1c 0.121 0.214 0.026




Table 4.3: Significant paths and summarized causal effects for each variable in the
path analysis for male. Dietary variables in the path analysis include energy, protein,
carbohydrate, total sugars, total fat and moisture. Only significant direct effects
and indirect effects no less than 0.01 are reported in the table. For indirect effects,
intermediate path coefficients are reported in 2nd to 4th columns under the column






Physical Activity ->BMI -0.224
Physical Activity ->Moisture 0.239
Physical Activity ->BMI ->HbA1c -0.224 0.256 -0.057





Age ->Total Sugars -0.121
Age ->Energy ->HbA1c -0.136 -0.473 0.064
Age ->Carbohydrate ->HbA1c -0.135 0.223 -0.03
Age ->Energy ->BMI ->HbA1c -0.136 -0.452 0.256 0.016
Total effects on HbA1c 0.295
Mexican American
MexA ->Protein 0.321




NHB ->Total Sugars -0.233
NHB ->Moisture -0.375
NHB ->Carbohydrate ->HbA1c -0.239 0.223 -0.053
NHB ->Moisture ->BMI ->HbA1c -0.375 0.107 0.256 -0.01




Energy ->BMI ->HbA1c -0.452 0.256 -0.116
Total effects on HbA1c -0.589
Protein
Protein ->BMI 0.117




Carbohydrate ->BMI ->HbA1c 0.075 0.256 0.019
Total effects on HbA1c 0.242
Total Fat
Total Fat ->HbA1c 0.271
Total Fat ->BMI 0.277
Total Fat ->BMI ->HbA1c 0.277 0.256 0.071
Total effects on HbA1c 0.342
Moisture
Moisture ->BMI 0.107




Table 4.4: Significant paths and summarized causal effects for each variable in the
path analysis for female. Dietary variables in the path analysis include energy, protein,
carbohydrate, total sugars, total fat and moisture. Only significant direct effects
and indirect effects no less than 0.01 are reported in the table. For indirect effects,
intermediate path coefficients are reported in 2nd to 4th columns under the column






Physical Activity ->Magnesium 0.230
Physical Activity ->Magnesium ->HbA1c 0.230 -0.171 -0.039
Physical Activity ->Magnesium ->BMI ->HbA1c 0.230 -0.257 0.197 -0.012






MexA ->Magnesium ->HbA1c 0.389 -0.171 -0.067
MexA ->Phosphorus ->BMI ->HbA1c 0.244 0.214 0.197 0.010
MexA ->Magnesium ->BMI ->HbA1c 0.389 -0.257 0.197 -0.020





NHB ->BMI ->HbA1c 0.382 0.197 0.075
Total effects on HbA1c 0.348
SES
SES ->BMI -0.096
SES ->BMI ->HbA1c -0.096 0.197 -0.019
Total effects on HbA1c -0.115
Phosphorus
Phosphorus ->BMI 0.214




Magnesium ->BMI ->HbA1c -0.257 0.197 -0.050
Total effects on HbA1c -0.478
Moisture
Moisture ->BMI 0.134
Moisture ->BMI ->HbA1c 0.134 0.197 0.026
BMI
BMI ->HbA1c 0.197
Table 4.5: Significant paths and summarized causal effects for each variable in the
path analysis for Mexican American by gender. Only significant direct effects and









Table 4.6: Significant paths and summarized causal effects for each variable in the
path analysis for non-Hispanic black by gender. Only significant direct effects and











Physical Activity ->Magnesium 0.295
Physical Activity ->Magnesium ->HbA1c 0.295 -0.246 -0.073
Education
Education ->Magnesium 0.212
Education ->Magnesium ->HbA1c 0.212 -0.246 -0.052
Energy
Energy ->BMI 0.328
Energy ->BMI ->HbA1c 0.328 0.145 0.048
Carbohydrate
Carbohydrate ->BMI -0.489










Table 4.7: Significant paths and summarized causal effects for each variable in the
path analysis for non-Hispanic white by gender. Only significant direct effects and










Age ->Total Sugars -0.167
Age ->Energy ->HbA1c -0.149 -0.578 0.086
Age ->Energy ->BMI ->HbA1c -0.149 0.286 0.239 -0.01
Age ->Carbohydrate ->HbA1c -0.168 0.322 -0.054
Age ->Carbohydrate ->BMI ->HbA1c -0.168 -0.39 0.239 0.016






Energy ->BMI ->HbA1c 0.286 0.239 0.069






Carbohydrate ->BMI ->HbA1c -0.39 0.239 -0.093
Total Fat
Total Fat ->HbA1c 0.212
Thiamin (Vitamin B1)
Thiamin VitB1 ->BMI 0.122







Physical Activity ->BMI -0.356






Alcohol ->BMI ->HbA1c -0.193 0.228 -0.044
SFA 4:0 (Butanoic)
SFA 40 Butanoic ->BMI -0.136




Figure 4.1: Hypothesis causal model (Adapted from Wright, 1934). X1 and X2
indicate demographic characteristics or physical activity. N1 and N2 are nutrition
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This section includes the additional figures and tables in Chapter 2.
Table A1.1: All possible candidate profiles with nodal parameters for T = 4. Nodal
parameters for ORI method are defined as the parameters linked to all the other pa-
rameters where the two parameters are considered as linked if the inequality between
them is pre-specified.
Candidate Profiles Nodal Parameters
C0 : µ1 = µ2 = µ3 = µ4 -
C1 : µ1 < µ2 < µ3 < µ4 µ1, µ2, µ3, µ4
C2 : µ1 < µ2 < µ3 > µ4 µ3
C3 : µ1 < µ2 > µ3 < µ4 None
C4 : µ1 < µ2 > µ3 > µ4 µ2
C5 : µ1 > µ2 < µ3 < µ4 µ2
C6 : µ1 > µ2 < µ3 > µ4 None
C7 : µ1 > µ2 > µ3 < µ4 µ3



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table A1.3: Selected profiles and the percentage of J = 35 sites assigned to each
profile for T = 5 and T = 8 in simulation study of Section 2.4.2.
Selected Profiles % Assigned to Profile
T = 5
C0 : µ1 = µ2 = µ3 = µ4 = µ5 20%
C1 : µ1 < µ2 < µ3 < µ4 < µ5 10%
C2 : µ1 < µ2 > µ3 > µ4 > µ5 10%
C3 : µ1 < µ2 < µ3 > µ4 > µ5 5%
C4 : µ1 < µ2 < µ3 < µ4 > µ5 10%
C5 : µ1 > µ2 < µ3 < µ4 < µ5 5%
C6 : µ1 > µ2 > µ3 < µ4 < µ5 5%
C7 : µ1 > µ2 > µ3 > µ4 < µ5 10%
C8 : µ1 > µ2 > µ3 > µ4 > µ5 10%
C9 : µ1 < µ2 < µ3 > µ4 < µ5 5%
C10 : µ1 < µ2 > µ3 < µ4 < µ5 10%
T = 8
C0 : µ1 = µ2 = µ3 = µ4 = µ5 = µ6 = µ7 = µ8 20%
C1 : µ1 < µ2 < µ3 < µ4 < µ5 < µ6 < µ7 < µ8 5%
C2 : µ1 < µ2 > µ3 < µ4 < µ5 < µ6 < µ7 < µ8 5%
C3 : µ1 < µ2 > µ3 < µ4 > µ5 < µ6 < µ7 < µ8 5%
C4 : µ1 < µ2 < µ3 < µ4 > µ5 > µ6 > µ7 > µ8 10%
C5 : µ1 < µ2 < µ3 < µ4 > µ5 < µ6 > µ7 > µ8 5%
C6 : µ1 < µ2 < µ3 < µ4 < µ5 < µ6 > µ7 > µ8 5%
C7 : µ1 < µ2 < µ3 < µ4 < µ5 < µ6 < µ7 > µ8 10%
C8 : µ1 > µ2 > µ3 < µ4 < µ5 > µ6 < µ7 < µ8 5%
C9 : µ1 > µ2 > µ3 < µ4 < µ5 < µ6 > µ7 < µ8 5%
C10 : µ1 > µ2 > µ3 > µ4 < µ5 < µ6 < µ7 < µ8 5%
C11 : µ1 > µ2 > µ3 > µ4 > µ5 < µ6 > µ7 < µ8 5%
C12 : µ1 < µ2 > µ3 > µ4 > µ5 > µ6 < µ7 > µ8 5%
C13 : µ1 > µ2 > µ3 > µ4 < µ5 > µ6 < µ7 < µ8 5%
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Figure A1.1: Estimated Trajectory with 95% credible interval (1st and 3rd columns)
and MPW estimators (2nd and 4th columns) of proteins 1-10. The colored lines
represent the observed phosphorylation abundance of each of the five patients. The
boxes of MPW plots represent the posterior probabilities between each of two adjacent











































































































































































































































































































Figure A1.2: Estimated Trajectory with 95% credible interval (1st and 3rd columns)
and MPW estimators (2nd and 4th columns) of proteins 11-20. The colored lines
represent the observed phosphorylation abundance of each of the five patients. The
boxes of MPW plots represent the posterior probabilities between each of two adjacent






































































































































































































































































































































Figure A1.3: Estimated Trajectory with 95% credible interval (1st and 3rd columns)
and MPW estimators (2nd and 4th columns) of proteins 21-30. The colored lines
represent the observed phosphorylation abundance of each of the five patients. The
boxes of MPW plots represent the posterior probabilities between each of two adjacent

































































Figure A1.4: Estimated Trajectory with 95% credible interval (1st and 3rd columns)
and MPW estimators (2nd and 4th columns) of proteins 31-32. The colored lines
represent the observed phosphorylation abundance of each of the five patients. The
boxes of MPW plots represent the posterior probabilities between each of two adjacent
time points, and the shaded box indicates the MPW-selected classifications.
98
Appendix 2
This section includes the derivation of the estimated variance of the superiority score
obtained from the propensity score-based matching in Chapter 3.








i ). Then in the propensity



























Then the estimated variance for γˆMat is derived as follows.
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